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Abstract 
Erin Jayne Heenan: G Protein Signaling at the Endosome 
(Under the direction of Henrik G. Dohlman, Ph.D.) 
 
 G protein coupled signal pathways are conserved from plants to fungi to humans, 
and mediate the responses to a diverse array of signals including pheromones, light, 
odorants and neurotransmitters.  In the yeast Saccharomyces cerevisiae, activation of a G 
protein pathway by pheromone triggers a series of events leading to mating.  Traditional 
paradigms have assumed that the pathway originates solely from the plasma membrane, 
and that the purpose of the Gpa1Gα protein is to sequester the Ste4/Ste18Gβγ dimer in the 
absence of stimulus.  However, evidence has come to light showing that the activated 
Gpa1Gα protein transduces a signal, and this signal originates from the endosome.  
Moreover, the catalytic and regulatory subunits of the only phosphatidylinositol-3-kinase 
in yeast, Vps34 and Vps15, are required to transmit this endosomal signal.  The 
endosomal G protein signal activates many of the same events as the plasma membrane 
derived signal, and results in activation of the MAPK Fus3 in preference to Kss1. 
 Here, we show that the kinase domain with the intermediate domain of Vps15 is 
both necessary and sufficient for binding to Gpa1 and for transmitting the G protein 
coupled signal.  The WD domain of Vps15 most likely serves as a scaffold to assemble 
binding partners, and folds into a 7-bladed propeller, as demonstrated by X-ray 
crystallography.  Moreover, our investigation of the kinase domain of Vps15 shows that  
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fully activated Vps34 is also necessary for both the expression and phosphorylation of 
Vps15.
Finally, as Fus3 is preferentially activated at the endosome, we investigated the 
regulation of Fus3.  Here, we show that Fus3 is positively and negatively regulated by 
PtdIns(3)P, a second messenger produced by Vps34 that localizes to the endosomes.  
Furthermore, we show that lysine and histidine point mutations of Fus3 in its basic patch 
result in a decrease of Fus3 ubiquitination at the lysine residue as well as a decrease in 
Fus3 phosphorylation of Far1.  Together, these data further our knowledge of the 
differences between the endosomal and plasma membrane G protein pathways. 
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Chapter 1 
Introduction
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For organisms to survive and reproduce, they must respond quickly and 
efficiently to external stimuli.  In organisms from plants to fungi to humans, it is G 
protein-coupled receptors that mediate the responses of the cells to a wide array of 
stimuli, including light, neurotransmitters, odorants and pheromones.  In humans, G 
protein-coupled receptors respond to serotonin, epinephrine, and thrombin among others.  
It is estimated that 30-50% of all drugs on the market today target G protein receptors and 
constituents of their pathways.  Many of the drugs targeting G protein receptors, such as 
antihistamines and antidepressants, are some of the most commonly used in medicine 
today.  A greater understanding of how these receptors are activated, and the members of 
their pathways, is therefore a critical goal in the pursuit of new drug targets (1-4). 
 
G Protein Signaling: A Historical Perspective 
 The study of G protein signaling has a long and storied history, dating back to the 
early twentieth century and reaping no fewer than eight Nobel Prizes in Physiology or 
Medicine.  The earliest inklings of the existence of GPCR’s came in the first years of the 
twentieth century from Paul Ehrlich (Nobel Prize in Physiology or Medicine, 1908), who 
speculated that there must be a “receptive substance” that recognized chemical structures.  
His observations were supported by John Langley, a co-discoverer of acetylcholine, who 
posited around 1910-1915 that neurotransmitters act by being released and interacting 
with a receptive substance.  However, it was not until the 1970’s that it was commonly 
accepted that the receptor was really a protein (5). 
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 In the 1950’s, Earl Sutherland (Nobel Prize in Physiology or Medicine, 1971), 
performed elegant experiments discovering the mechanisms of action of many hormones, 
including epinephrine, and the second messengers that regulate them, most particularly 
cyclic AMP.  In the early 1970’s, Martin Rodbell (Nobel Prize in Physiology or 
Medicine, 1994) showed that it is GTP, not ATP, that is necessary for hormone activation 
by the guanine nucleotide protein (now known as the G protein).  It was Alfred Gilman 
(Nobel Prize in Physiology or Medicine, 1994) who actually discovered, and eventually 
purified, the protein we now know as the G protein in the late 1970’s and early 1980’s.  
In 1977, Robert Lefkowitz purified the first receptor, the β-adrenergic receptor, and 
showed that it is a separate entity from adenylate cyclase (5).  In the three decades that 
have followed these discoveries, the field of GPCRs and G proteins has exploded, and G 
proteins have been shown to be essential to the most key aspects of life. 
 
Heterotrimeric G Protein Signaling 
G protein-coupled receptors are comprised of seven membrane-spanning regions 
and transmit signals via G proteins, which are composed of a heterotrimeric complex 
containing a Gα, a Gβ, and a Gγ subunit.   Upon activation by ligand binding, the G 
protein-coupled receptor catalyzes the exchange of GTP for GDP on the Gα subunit.  
This exchange leads to the dissociation of Gα from the Gβγ complex, which allows the 
free Gα and Gβγ the opportunity to activate downstream effectors.  The signal 
transmitted by the free Gα and Gβγ subunits continues until the GTP of Gα is hydrolyzed 
to GDP, resulting in re-association of Gα with the Gβγ heterodimer.  Regulators of G-
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protein signaling serve to speed up the rate of GTP hydrolysis by Gα, promoting re-
association of the Gα and Gβγ subunits and inactivating the signaling cascade (1, 6). 
 
Yeast as a Model System 
Yeast are a powerful tool for eukaryote genetic analysis.  Yeast can be grown as 
haploids, which facilitates the study of recessive mutations.  The entire yeast genome has 
been sequenced and nearly every open reading frame has been deleted.  Additionally, 
yeast easily undergo homologous recombination, allowing the investigation by gene 
disruption.  Furthermore, there are a wide variety of tools readily available for the study 
of G protein signaling in yeast, including GFP-tagged libraries and the previously 
mentioned deletion library. The G protein-mediated pheromone-response pathway is one 
of the best understood signal transduction pathways in eukaryotes.  The components and 
mechanism of signal transmission in the yeast pheromone response-pathway are highly 
conserved in many pathways in humans, including those responsible for hormone and 
sensory responses, which makes yeast an ideal model system for the study of G protein 
signaling (7-10). 
 
G Protein Signaling in the Yeast Pheromone Pathway 
In Saccharomyces cerevisiae, a G protein-mediated pathway is employed for 
communication between cells to sense pheromones, resulting in mating.  In yeast, there 
are two different haploid cell types, MATa and MATα.  These two cell types secrete 
pheromones in the form of small peptides, called a-factor and α-factor, respectively. The 
a-factor binds to an a-factor specific G protein coupled receptor called Ste3 on MATα 
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cells, and the α-factor binds to an α-factor specific receptor called Ste2 on MATa cells.  
In MATa cells, upon pheromone binding to Ste2, the receptor activates the G protein 
heterotrimer comprised of Gpa1 (Gα subunit) and a Ste4/Ste18 heterodimer (Gβ/γ 
subunits respectively).  Upon activation, Gpa1 exchanges its bound GDP for GTP.  GTP-
bound, or activated, Gpa1 then dissociates from the Ste4/Ste18 heterodimer.  Dissociation 
of Gpa1 and Ste4/Ste18 leads to signal transmission through activation of the components 
of the mitogen-activated protein kinase (MAPK) cascade: Ste20, Ste11, Ste7, and Fus3, 
as well as the MAPK scaffold protein, Ste5, and a transcription factor, Ste12.  Fus3 is a 
MAPK activated by the MAPKK Ste7.  The activation of Fus3 by Ste7 leads to the 
phosphorylation of various proteins in the cell that mediate the arrest of cell division, cell 
morphology changes and gene transcription (Figure 1.1).  One of the proteins that Fus3 
phosphorylates is Far1.  Far1 carries Cdc24, another effector of G protein signaling, as its 
cargo.  Upon activation of the cell by pheromone, Far1 is exported from the nucleus.  A 
complex formed of Far1-Cdc24-Ste4-Ste18 localizes at the mating projection, known as 
the shmoo tip, following pheromone stimulation, and is believed to play a pivotal role in 
the formation of the mating projection.  Additionally, Far1 is postulated to play a key part 
in the imposition of pheromone mediated cell cycle arrest in G1 by acting as an inhibitor 
of Cdc28, a cyclin dependent kinase that is required for the cell to progress through G1 
(1, 11-13).   
 
Posttranslational Modifications and G Protein Signaling 
The effect of posttranslational modifications on the regulation and propagation of 
G protein signals has been an area of detailed study.  The posttranslational modification 
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of greatest interest to the G protein community has long been phosphorylation, which has 
been shown to play a large role in the regulation of both G proteins and MAP kinases (1).  
Phosphorylation plays a key role in the activation of the MAPK cascade and Far1 (1, 13, 
14).  Recently, the posttranslational modification ubiquitination, in which a small protein 
precursor called ubiquitin is added to specific lysine residues within a protein, has come 
to light as an important regulator in the propagation of G protein signals in cells.  Poly-
ubiquitination generally leads to degradation of the modified protein and has been shown 
to be important in the regulation of many components of the G protein signaling pathway 
(15-20). 
 
In yeast, many key proteins in the G protein signaling pathway have been shown 
to be ubiquitinated, including Ste2, Gpa1, Ste7, and Ste12 (15-21).  Mono-ubiquitination 
of Ste2 results in an internalization of the receptor and serves as a signal to direct the 
protein into the vacuole for degradation (21-23).  Ste7 is ubiquitinated following its 
phosphorylation and activation by Ste11.  The ubiquitination of Ste7 results in its 
degradation (24).  Ste12 is also ubiquitinated and degraded in a pheromone-dependent 
manner (20).  Unusually, Gpa1 is both poly- and mono-ubiquitinated, and the two 
different mechanisms of ubiquitination result in two very different outcomes.  Mono-
ubiquitination of Gpa1 targets it to the vacuole, while polyubiquitination of Gpa1 targets 
it to the proteasome (19).  A similar panel of proteins involved in G protein signaling in 
mammals have also been shown to be ubiquitinated.   Therefore, an enrichment of our 
understanding of the role of ubiquitination in the modulation of G protein pathways is 
extremely important to our understanding of the pathway as a whole (17).   
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Signaling by Activated Gpa1 
As might be expected, mutations in Gpa1 that prevent it from binding to Gβγ do 
not block G protein-coupled signaling but instead result in uncontrolled signaling by free 
Gβγ, while overexpression of Gpa1 leads to decreased signaling, presumably due to a 
titration of free Gβγ.  This evidence led to the supposition that Gβγ alone was sufficient 
to propagate the mating response signal, and that the role of Gα was to sequester Gβγ 
when no pheromone was present.  Information has come to light that shows Gα itself 
plays an important role in the propagation of the G-protein coupled signal apart from its 
long-understood role of sequestering Gβγ (1, 25, 26).   
 
 Previous studies revealed that some organisms appear to have cooperative and 
antagonistic signaling regulation by both the Gα and Gβγ subunits (27).  These studies 
prompted the Dohlman lab to examine whether Gpa1 could activate any part of the 
signaling pathway leading to mating events in yeast.  It was found that Gpa1Q323L, a 
mutant form of Gpa1 that is permanently active as it contains a mutation that blocks GTP 
hydrolysis, was able to activate many of the same events usually induced by Gβγ, such as 
morphological changes and new gene transcription, but not growth arrest.  
Overexpression of Gpa1Q323L also led to increased activation of the MAP kinase pathway, 
as measured by Fus3 phosphorylation. This GTPase deficient mutant did not affect 
signaling by Gβγ, as Gβγ does not bind the GTP-bound form of Gpa1 (26).  Additionally, 
it was found that, while Gpa1 localizes primarily at the plasma membrane, constitutively 
active Gpa1Q323L localizes at the endosome (28).  
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Identifying Effectors for Activated Gpa1 
 A screen was performed to identify potential effectors of Gpa1Q323L.  In this 
screen, transcriptional activation was monitored in 4847 yeast strains, each containing a 
different, known, gene deletion.  The activity of the pathway was monitored using a 
reporter gene under the control of a pheromone-inducible promoter.  This assay allows 
screening for those mutants that affect the mating pathway (28). 
 
 Seven mutants were identified that suppressed signaling by Gpa1Q323L in multiple 
assays.    The two mutants that provoked the most interest were Vps15 and Vps34, as 
they are already well known to play a role in other forms of signaling through the 
production of PI3P.  Vps15 and Vps34 act as the regulatory and catalytic subunits, 
respectively, of the only phosphatidylinositol 3-kinase (PI3K) that is present in yeast (28, 
29).  Transformation of the deletion strains with the missing Vps15 or Vps34 restored 
signaling, confirming that these proteins are required for Gpa1Q323L signaling (28).   
 
Vps15 and Vps34  
 Vps15 and Vps34 are classified as a Class III PI3K (30, 31).   While it is well 
established that Class I PI3Ks are regulated by G protein coupled receptors, it has not 
previously been shown that Class III PI3Ks are regulated by G proteins (31).  Class III 
(Vps34) PI3Ks are unique among other PI3Ks in that they are capable of utilizing just 
one substrate, phosphatidylinositol.  As a result of this substrate specificity, Vps34 makes 
just one phosphoinositide product- PI3P.  That Vps15 and Vps34 comprise the only PI3K 
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present in yeast makes the study of PI3P in yeast much more straightforward than it is in 
organisms with other PI3Ks, as all PI3P present in yeast must be made by Vps34 (29). 
 
In addition to their described role in G protein-coupled signaling in yeast, Vps15 
and Vps34 play integral roles in many other functions of the cell, including vesicular 
trafficking, nutrient sensing, and autophagy (29).  The structure of Vps15 consists of a 
predicted protein kinase domain, with a central region containing multiple heat repeats, 
and a C-terminal WD-40 repeat domain (29, 32, 33).  Vps15 has been shown to be a 
Ser/Thr protein kinase, and is believed to autophosphorylate (33, 34).  However, other 
substrates for the kinase activity have never been identified, and Vps34 has been shown 
to autophosphorylate (33).  Mutation of the protein kinase activity of Vps15 has been 
shown to abrogate its association with binding partners, including Vps34, as well as 
many of its functions in the cell, including G protein signaling (28, 33, 35, 36). 
 
 vps15Δ and vps34Δ strains are most similar to Class D vps mutants, and like some 
Class D mutants they have a mostly normal vacuolar morphology, but have deficiencies 
in vesicular sorting and vacuolar segregation (29, 37).  vps15Δ and vps34Δ  strains also 
are sensitive to growth at 37°C and to osmotic stress (33, 34).  Additionally, in kinase 
dead Vps15, or vps15Δ cells, PI3P production by Vps34 is abolished (36, 38).  
Emphasizing the importance of the kinase domain of Vps15 is the fact that, when Vps34 
is expressed at endogenous levels, Vps15 with an intact kinase domain is required for the 
activity of Vps34.  Interestingly, overexpressed Vps34 can compensate for defective 
growth at elevated temperatures when expressed with single point mutations of the kinase 
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domain of Vps15, but overexpression of Vps34 can not compensate for a lack of Vps15 
or for a triple mutation in the kinase domain of Vps15 (39). 
 
 Vps15 and Vps34 are present in at least four distinct complexes in yeast (Figure 
1.2), and are known to bind to each other (29).  Residues 837-864 of Vps34 are sufficient 
to bind to the kinase domain and heat repeats of Vps15, which are required to bind Vps34 
(35).  The first Vps15-Vps34 complex, which is required for autophagy, also contains 
Vps30, and Atg14.  Interestingly, we observed that the middle third of Atg14 has some 
sequence homology to typical Gγ proteins.  In the second complex, which is required for 
the proper vesicular sorting of many proteins including the lysosomal hydrolase 
carboxypeptidase Y, Vps15, Vps34, Vps30 and Vps38 are present.  The third complex, 
required for the sorting of several vesicular proteins, including Protein A and B, contains 
Vps15, Vps34 and potentially other, as yet unidentified, proteins.  The fourth complex is 
the one responsible for G protein signaling, and it contains Vps15, Vps34, Gpa1 and 
potentially other, unidentified, proteins (28, 29, 40-44). 
 
 The production of PI3P by Vps34 is critical for the function of many pathways.  It 
is thought that Vps34 regulates signaling by the recruitment of proteins that possess PI3P 
binding domains (29).  PI3P binding domains include FYVE domains, zinc-finger 
binding domains (45), and PX domains (46).  Pathways mediated by PI3P include, but 
are not limited to, assembly of PI3P binding proteins to regulate early endosomal docking 
and fusion (47, 48), the ubiquitin dependent sorting of internalized membrane proteins 
(49), and assembly of the retromer complex required for endosome to Golgi transport 
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(50).  Additionally, as described in greater detail below, activation of the G protein 
signaling pathway has been shown to require Vps34, which produces PI3P, as well as 
increased production of PI3P, indications that PI3P may also play some role in mediating 
or regulating the G protein-coupled signal (28, 51). 
 
G Protein Signaling at the Endosome 
Vps15 and Vps34 were found to be necessary for multiple aspects of the 
pheromone-mediated response. vps15Δ, and vps34Δ yeast strains have diminished growth 
arrest, MAPK activation, mating, and gene transcription (28).  Mutational inactivation of 
PI3K activity (28, 41), inactivation of the protein kinase activity of Vps15 (28, 39), and 
pharmacological inhibition of Vps34 using wortmannin (28, 38) also diminished mating, 
growth arrest, MAPK activation and gene transcription, indicating that Vps15 and Vps34 
are required for all aspects of the Gpa1Q323L pheromone-mediated signaling pathway (28).  
These data are an indication that it is Vps15 and Vps34, and their PI3-kinase and ser/thr 
kinase activities, that are required for the Gpa1Q323Lsignaling pathway (28). 
 
In addition, it was shown that Gpa1 binds directly to Vps15 preferentially in its 
unactivated (GDP-bound) state and to Vps34 preferentially in its activated (GTP-bound) 
state (28).  Vps34 binding to GTP-bound Gpa1 is interesting since binding to the 
activated form of a protein is a hallmark of an effector.  Vps15 binding to GDP-bound 
Gpa1 is interesting as this is a hallmark of a Gβ protein.  We were also intrigued by the 
WD-40 repeat domains of Vps15, as possessing 7 WD repeats is another hallmark of Gβ 
proteins (52, 53).  In addition to these structural hallmarks, overexpressed Gpa1Q323L 
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stimulated the PI3-kinase activity of the Vps15/Vps34 complex as monitored by an 
increase in phosphatidylinositol-3-phosphate (PI3P).  Gpa1Q323L activation also 
stimulated recruitment of the PI3P binding protein Bem1 to the endosomal membrane, 
and this recruitment was abolished in a vps34Δ yeast strain (28). 
 
It is known that Vps15 and Vps34 colocalize at several cellular organelles, 
including the endosome, Golgi, and vacuolar membrane (33, 54).   Using fluorescence 
microscopy, wildtype Gpa1 was found to localize primarily at the plasma membrane as 
would be expected (28, 54).  Constitutively active Gpa1Q323L was found instead to co-
localize with Snf7 (endosome epecific marker) and Vps34 at the endosome.  Deletion of 
Vps15 or Vps34 resulted in a decrease in Gpa1Q323L at the endosome and an increase in 
Gpa1Q323L at the plasma membrane, indicating that Vps15 and Vps34 promote endosomal 
localization of Gpa1 (28).   
 
In the work presented in this thesis, I sought to further elucidate the role of 
endosomal G protein signaling by clarifying the role of Vps15 in transmitting the signal, 
as well as further characterizing how Fus3 is regulated.  In Chapter II, I further 
investigate the role of Vps15 in G protein signaling.  Here, we show that, as predicted, 
Vps15 contains 7WD repeats in a manner that is remarkably similar to Gβ proteins.  
However, it is the kinase domain with the intermediate domain of Vps15 that is both 
necessary and sufficient to bind to both Gpa1Gα and to Atg14, a protein with sequence 
homology to Gγ proteins that is in complex with Vps15 during autophagy.   Finally, I 
show that it is the kinase domain with the intermediate domain of Vps15 that is both 
13 
necessary and sufficient to transmit the G protein-coupled signal.  We hypothesize that 
while the kinase domain with the intermediate domain is necessary to transmit the signal, 
it is the WD domain that acts as a scaffold to assemble various interacting partners of 
Vps15. 
 
As previously described, activated Gpa1 preferentially activates Fus3 over Kss1 
when transmitting the G protein signal at the endosome.  We sought to further elucidate 
the role of Fus3 in conducting the G protein signal in Chapter III.  Here, we show that 
PI3P both positively and negatively (at very high concentrations) affects the kinase 
activity of Fus3.  We also found point mutations in the basic patch of Fus3 that do not 
affect its general kinase activity or its role in mediating reporter gene transcription 
following pheromone stimulation of the cells.  However, these point mutations do result 
in reduced growth arrest, Far1 phosphorylation in vivo and ubiquitination.  The 
identification of specific residues in Fus3 that can uncouple the two branches of the 
pheromone response pathway mediated by Fus3 will prove to be a valuable tool for 
further investigation of G protein signaling and the differential activation of Fus3 and 
Kss1 from both the plasma membrane and the endosome. 
 
As the kinase domain of Vps15 is important in G protein signaling, in Chapter IV 
we undertook a further investigation of the kinase domain.  Here, I confirm that Vps15 
does indeed undergo a phosphorylation event, and that a point mutation in the kinase 
domain of Vps15 is capable of blocking this event.  Furthermore, we show that the 
presence of Vps34 is necessary for phosphorylation of Vps15.  However, additional 
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experimentation shows that fully active Vps34 is also necessary for expression of Vps15, 
leaving the exact role of Vps34 in Vps15 phosphorylation an open question.  Current 
efforts are underway to attempt to separate Vps34’s role in promoting stable expression 
of Vps15 and any role Vps34 might play in the phosphorylation of Vps15. 
 
The mechanism and components of the pheromone response pathway in yeast are 
highly conserved among eukaryotes, including humans.  Therefore, a greater 
understanding of this pathway is a key component in the understanding of how signaling 
in humans proceeds and why it goes amiss in many diseases.  Characterizing the novel 
effectors in the endosomal G protein pathway may lead to the discovery of other unique 
effectors.  Finally, gaining a better understanding of the G protein signaling pathway at 
the endosome could allow for the discovery of new potential drug targets as it gives us a 
better understanding of how G protein signals are transmitted in cells. 
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FIGURE LEGENDS 
 
 
Figure 1.1.  G protein signaling in Saccharomyces cerevisiae.  Schematic overview of 
the pheromone-activated G protein signaling pathway in yeast.  Key components of the 
pathway that originates at the plasma membrane and the pathway that originates at the 
endosome are shown. 
 
Figure 1.2.  Complexes of Vps15 and Vps34.  The four primary different complexes 
that Vps15 and Vps34 are known to be present in are shown.  The major functions of 
these complexes are indicated. 
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Figure 1.2 
 
 
 
 
Chapter 2 
 
Structure and Function of Vps15 in the Endosomal G Protein Signaling Pathway 
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ABBREVIATIONS 
α-MF, alpha mating factor; CPY, carboxypeptidase Y; G6PDH, glucose-6-phosphate 
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Guanosine-5'-triphosphate; ID, intermediate domain; IP, immunoprecipitation; KD, 
kinase domain; MAP, mitogen-activated protein; PD, pulldown; PtdIns, 
phosphatidylinositol;  SDS-PAGE, sodium dodecyl sulfate – polyacrylamide gel 
electrophoresis; VPS, vacuolar protein sorting; WD, tryptophan-aspartate 
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ABSTRACT 
 
G protein-coupled receptors mediate cellular responses to a wide variety of 
stimuli, including taste, light and neurotransmitters. In the yeast Saccharomyces 
cerevisiae, activation of the pheromone pathway triggers events leading to mating. The 
view had long been held that the G protein-mediated signal occurs principally at the 
plasma membrane. Recently, it has been shown that the G protein α subunit Gpa1 can 
promote signaling at endosomes and requires two components of the sole 
phosphatidylinositol-3-kinase in yeast, Vps15 and Vps34. Vps15 contains multiple WD 
repeats and also binds to Gpa1 preferentially in the GDP-bound state; these observations 
led us to hypothesize that Vps15 may function as a G protein β subunit at the endosome. 
Here we show an X-ray crystal structure of the Vps15 WD domain that reveals a seven-
bladed propeller resembling that of typical Gβ subunits. We show further that the WD 
domain is sufficient to bind Gpa1 as well as to Atg14, a potential Gγ protein that exists in 
a complex with Vps15. The Vps15 kinase domain together with the intermediate domain 
(linking the kinase and WD domains) also contributes to Gpa1 binding, and is necessary 
for Vps15 to sustain G protein signaling. These findings reveal that the Vps15 Gβ-like 
domain serves as a scaffold to assemble Gpa1 and Atg14, whereas the kinase and 
intermediate domains are required for proper signaling at the endosome. 
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BACKGROUND AND INTRODUCTION 
G protein-coupled receptors are highly conserved in organisms from yeast to 
humans. Upon stimulation, the receptor activates a G protein heterotrimer, causing the 
Gα subunit to release GDP, bind GTP, and dissociate from the Gβγ heterodimer. 
Following dissociation, the Gα and Gβγ subunits are able to activate downstream effector 
proteins (1-3). Examples include adenylyl cyclase, MAP kinases, phosphatidylinositol 
(PtdIns) 3-kinase, and phospholipase C-β (4). 
 
In simple eukaryotes such as yeast, G protein-coupled receptors mediate 
processes essential for proper cell functioning including mating. MATa and MATα cell 
types secrete small peptide pheromones, called a-factor and α-factor, respectively, that 
promote cell fusion and the formation of an a/α diploid. Activation of the pathway by 
pheromone leads to phosphorylation of various proteins that mediate new gene 
transcription, altered cell morphology, cell division arrest, and eventually cell fusion. Gβγ 
(Ste4/Ste18) initiates the pathway that originates from the plasma membrane and results 
in activation of the MAP kinases Fus3 and Kss1 (2). Gα (Gpa1) initiates a parallel 
pathway that operates at the endosomal membrane and results in activation of Fus3 in 
preference to Kss1 (5). The pathway originating from the endosome requires Vps15 and 
Vps34, the regulatory and catalytic subunits of the only PtdIns 3-kinase known in yeast 
(5-12). Further, Vps15 directly binds the unactivated (GDP-bound) form of Gpa1, while 
Vps34 directly engages the activated (GTP-bound form) of Gpa1. Additionally, both 
Vps15 and Vps34 are necessary for recruitment of Gpa1 to endosomes (5). G protein 
activation of Vps34 results in elevated production of PtdIns 3-P, and leads to the 
28 
endosomal recruitment of phospholipid binding proteins (5). 
 
Vps15 is an extremely large protein (166 kDa) and contains several distinct 
domains. These include an N-terminal serine/threonine kinase domain (6, 8, 11, 12), a C-
terminal WD-repeat containing domain (5, 13), and an internal domain that bridges the 
kinase- and WD-domains. It has been shown previously that the kinase activity of Vps15 
is necessary for full activation of the G protein signal (5). However, the precise role of 
the kinase domain including any substrates is unknown. The internal domain contains 
several HEAT repeats that have been shown to be important for protein−protein 
interactions (hereafter referred to as the intermediate domain or ID) (13-15). The WD 
domain was of particular interest to us because of the recognized importance of the WD-
containing Gβ protein, Ste4, in the pheromone-mediated pathway that originates from the 
cell plasma membrane. 
 
Here, we examine the roles of the different domains of Vps15 in binding to Gpa1, 
as well as in transmitting the G protein signal. We demonstrate that the WD-domain of 
Vps15 has a seven-bladed propeller structure like that of known Gβ proteins. We show 
further that the Gβ-like domain acts in the manner of a scaffold to bring together proteins 
that propagate the pheromone response at the endosome. Finally, we show that it is the 
kinase domain with the intermediate domain that is necessary for Vps15 to transmit the G 
protein signal leading to activation of Fus3 as well as for other Vps15 signaling functions 
in the cell. 
 
29 
EXPERIMENTAL PROCEDURES 
 
Protein Expression and Purification 
The coding sequence of Vps15 WD repeat domain (residues 1027−1454) was 
amplified by PCR from S. cerevisiae BY4741 genomic DNA and inserted into a modified 
pFastBac vector through ligation independent cloning (16). Baculovirus coding for 
production of recombinant His
6
-Vps15 WD repeat domain was prepared according to the 
Bac-to-Bac method (Invitrogen). Two liters of High-Five insect cells cultured in Express 
Five SFM (Gibco) to a density of 2 × 10
6
 cells/mL were infected with the baculovirus for 
48 h at 27 °C. 
 
Cells were harvested by centrifugation at 4400g and resuspended in buffer A [20 
mM Tris pH 8.0, 300 mM NaCl, 10 mM imidazole, 10% (v/v) glycerol, 0.02% NaN
3
] 
with Complete EDTA-free protease inhibitor cocktail (Roche) and PMSF. The cells were 
lysed with three passes through an Emulsiflex C5 homogenizer (Avestin) operating at 
15000 psi, and the lysate was clarified by centrifugation at 105000g. The resulting 
supernatant was filtered through a 0.45 µm low protein binding filter and applied to a 1 
mL HisTrap HP column (GE Healthcare). The column was washed with 30 column 
volumes (CV) of buffer A followed by 30 CV of 5% buffer B (buffer A containing 1 M 
imidazole). His
6
-Vps15 WD repeat domain was eluted with a step gradient of 30% buffer 
B. To prevent aggregation during the elution, fractions of 1 mL were collected into tubes 
containing 2 mL buffer C [20 mM Tris pH 8.0, 300 mM NaCl, 2 mM EDTA, 10% 
glycerol (v/v), 2 mM DTT, 0.02% (w/v) NaN
3
]. The fractions containing the protein were 
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pooled immediately and applied to a Sephacryl S-300 26/60 column (GE Healthcare) 
equilibrated with buffer D (buffer C without EDTA). Vps15 WD repeat domain was 
eluted with buffer D and concentrated to 11 mg/mL in a Centriprep YM10 centrifugal 
concentrator (Millipore). Aliquots of the protein were quick frozen in liquid nitrogen and 
stored at −80 °C. 
 
Crystallization and Data Collection 
Crystals of the Vps15 WD repeat domain were grown at 18 °C by macroseeding 
small crystals into microbatch setups. The batch solution was prepared by quickly mixing 
the protein (6 mg/mL) with an equal volume of precipitant solution composed of 1.4 M 
ammonium malonate pH 6.5, 100 mM sodium acetate pH 4.6, 4% (v/v) isopropanol. 
Crystals suitable for X-ray diffraction were obtained within 7−10 days. Prior to data 
collection, crystals were cryoprotected by stepwise transfer into 20% (v/v) ethylene 
glycol in synthetic mother liquor (1.2 M ammonium malonate pH 6.5, 100 mM sodium 
acetate pH 4.6, 2% isopropanol), after which they were suspended in loops (Hampton 
Research) and quick frozen by immersion into liquid nitrogen. The crystals belong to the 
space group P3
1
21, with unit cell dimensions of a = b = 86.5 Å, c = 132.8 Å, and one 
molecule in the asymmetric unit. 
 
Crystals used in derivative screening were stabilized for several hours in synthetic 
mother liquor prior to soaking in heavy atom solutions. The gold derivative ultimately 
used to determine the phases was prepared with a 10 min soak in 5.8 mM KAu(CN)
2
. A 
single wavelength anomalous dispersion data set (λ = 11.917 keV) was collected from a 
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single crystal at the SER-CAT 22-BM beamline at the Advanced Photon Source 
(Argonne National Laboratory, Argonne, IL). A native data set was subsequently 
collected from a single crystal at the SER-CAT 22-ID beamline. All data were processed 
and scaled with HKL2000 (17). Relevant data collection and processing statistics are 
listed in Table 2.1. 
 
Phasing, Model Building and Refinement 
The positions of the gold atoms in the derivative crystal were found using the 
program SHELXD (18), and the correct hand for the coordinates was determined with 
SHELXE. Refinement of the gold atom coordinates and computation of the phases was 
performed with the CCP4 program MLPHARE, and the phases were subsequently 
improved with solvent flattening and histogram matching using the method of ref 19. The 
initial electron density map was easily interpretable, and 319 of the 437 residues in the 
protein were automatically fitted with the program ARP/wARP (20). Additional residues 
were built into the map using COOT (21). The structure of the His
6
-Vps15 WD repeat 
domain was completed using native protein data and iterative cycles of model building 
and refinement with COOT and the CCP4 program REFMAC (22). The final model has a 
crystallographic R-value of 20.9% (R-free 24.6%) for all data from 50 to 1.8 Å and 
includes residues 1031−1040, 1042−1386, 1389−1410, and 1424−1454. No electron 
density was present for the N-terminal histidine tag or Vps15 residues 1027−1030, 1041, 
1387, 1388, and 1411−1423. In the Ramachandran plot, 96.2% of the residues are in the 
most favored region, 3.0% are in the generously allowed region, and 0.8% are in the 
disallowed region. Relevant phasing and refinement statistics are listed in Table 2.2, and 
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representative electron density is shown in Supporting Figure 2.1, Supporting 
Information. 
 
Strains and Plasmids 
Standard methods for the growth, maintenance, and transformation of yeast and 
bacteria and for the manipulation of DNA were used throughout. Yeast Saccharomyces 
cerevisiae strains used in this study are BY4741 (MATa leu2Δ met15Δ his3Δ ura3Δ) and 
BY4741-derived gene deletion mutants (Invitrogen). The vps15Δ strain used is described 
in ref 5. 
 
Previously described yeast shuttle vectors and expression plasmids are pRS315-
ADH-Flag (CEN, amp
R
, LEU2, ADH1 promoter/terminator and either a Flag epitope that 
can be added 5′ with a SacI site or 3′ with an XmaI site), pRS316-ADH-Myc (CEN, 
amp
R
, URA3, ADH1 promoter/terminator and either a Myc epitope that can be added 5′ 
with a SacI site or 3′ with an XmaI site) (23), pAD4M-GST, pAD4M-Gpa1-GST, 
pRS316-ADH-Gpa1−2myc (24), pAD4M-Gpa2-GST (25), pRS423-FUS1-LacZ (26). 
Truncations of Vps15 were designed based upon the crystal structure of the WD domain 
of Vps15 (Figure 2.1) as well as domain predictions from SMART and three different 
secondary structure predictions (27-32). For naming purposes, Vps15 is considered to 
possess three domains: the kinase domain (KD) from residues 1−294, the WD domain 
(WD) from residues 1027−1454 and the intermediate domain (ID) spanning the region 
between the kinase domain and the WD domain. Plasmids pRS315-ADH-Flag-Vps15
KD
 
(using primers Vps15fn and Vps15ksrn), pRS315-ADH-Flag-Vps15
KD,ID
 (using primers 
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Vps15fn and Vps15klrn), pRS315-ADH-Flag-Vps15
ID,WD
 (using primers Vps15wdlfn 
and Vps15rn), pRS315-ADH-Flag-Vps15
WD
 (using primers Vps15wdsfn and Vps15rn), 
pRS316-ADH-Myc-Vps15
ID,WD
 (using primers Vps15wdlfn and Vps15rn), and pRS316-
ADH-Myc-Vps15
WD
 (using primers Vps15wdsfn and Vps15rn) were constructed by PCR 
amplification of VPS15 from BY4741 genomic DNA, incorporation of the product into a 
TOPO vector (Invitrogen), digestion by SacI, and ligation into pRS315-ADH-Flag or 
pRS316-ADH-Myc. Plasmids pRS315-ADH-Vps15
KD,ID,WD
-Flag (using primers Vps15fc 
and Vps15rc), pRS315-ADH-Vps15
ID,WD
-Flag (using primers Vps15wdlfc and Vps15rc), 
pRS315-ADH-Vps15
WD
-Flag (Vps15wdsfc and Vps15rc), pRS316-ADH-Vps15
WD
-Myc 
(using primers Vps15wdsfc and Vps15rc) were constructed by PCR amplification of 
VPS15 from BY4741 genomic DNA, incorporation into a TOPO vector (Invitrogen), 
digestion by XmaI and ligation into pRS315-ADH-Flag or pRS316-ADH-Myc. Plasmids 
pRS315-ADH-Flag-Atg14 (using primers Atg14fn and Atg14rn) and pRS316-ADH-
Myc-Atg14 (using primers Atg14fn and Atg14rn) were generated through PCR 
amplification of ATG14 from BY4741 genomic DNA, incorporation of the product into 
TOPO vector, digestion by SacI, and ligation into pRS315-ADH-Flag or pRS316-ADH-
Myc. pRS316-ADH-3Myc-Atg14 was constructed by the annealing of two homologous 
oligonucleotides incorporating the sequence of 2 Myc epitopes as well as overhangs 
homologous to BamHI and SalI restriction sites (using the primer 2myc and its 
complement). pRS316-ADH-Myc-Atg14 was then digested with BamHI and SalI and 
ligated with the annealed oligonucleotides. Myc-Vps15
WD R1261A
 (using primer 
Vps15R1261A and its complement), Myc-Vps15
WD R1261K
 (Vps15R1261K and its 
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complement), Myc-Vps15
ID,WD R1261A
 (Vps15R1261A and its complement), Myc-
Vps15
ID,WD R1261K
 (Vps15R1261K and its complement), Vps15
KD,ID,WD R1261A
 Flag 
(Vps15R1261A and its complement), and Vps15
KD,ID,WD R1261K
 Flag (Vps15R1261K and 
its complement) in pRS316-ADH-Myc and pRS315-ADH-Flag respectively were created 
using QuikChange (Stratagene). Plasmid pRS306 Vps15
KD,ID,WD R1261A
-Flag was created 
by digestion of the pRS315 construct with BamHI and ligation into the corresponding 
BamHI site of pRS315 construct. Genomic integration was performed using HpaI. All 
plasmids described were confirmed by sequencing. 
 
Purification of Flag Epitope-tagged Proteins 
Plasmids pRS315-ADH-Flag-Vps15
KD
, pRS315-ADH-Flag-Vps15
KD,ID
, pRS315-
ADH-Vps15
KD,ID,WD
-Flag, pRS315-ADH-Flag-Vps15
ID,WD
, pRS315-ADH-Vps15
ID,WD
-
Flag, pRS315-ADH-Flag-Vps15
WD
, pRS315-ADH-Vps15
WD
-Flag, and pRS315-ADH-
Flag were transformed into either wildtype or atg14Δ cells expressing pRS316-ADH-
Myc, pRS316-ADH-Vps15
WD
-Myc, pRS316-ADH-Gpa1−2Myc, or pRS316-ADH-
3Myc-Atg14. A 50 mL culture of cells containing each plasmid was grown in SCD-Ura-
Leu until A
600 nm
  0.8. Cells were disrupted in buffer E (50 mM Tris-Cl pH 8.0, 200 mM 
NaCl, 0.1% Triton X-100, 25 mM beta-glycerophosphate, 1 mM EDTA, 2 protease 
inhibitor cocktail pellets per 50 mL (Roche)) for 15 min at 4 °C using a vortex fitted with 
a 60-microtube headpiece. Lysates were then combined at 4 °C with gentle rotation for 
25 min (this step omitted in several experiments) to ensure solubilization of membrane 
bound proteins. The lysates were then centrifuged at 16000g for 1 min, and then again for 
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25 min. Protein determination was performed for all samples, and each lane contains an 
equal total concentration and volume of protein. The supernatant was mixed with 40 µL 
of Flag affinity resin (Sigma-Aldrich) that had been equilibrated with buffer E. The 
lysates and beads were mixed with gentle rotation for 2 h at 4 °C. The beads were washed 
five times with 500 µL of buffer E. Bound proteins were then eluted from the beads with 
two 20 µL washes of 0.25 mg/mL 3× Flag Peptide (Sigma-Aldrich) and collected by 
centrifugation at 4900g for 1 min. 6× SDS buffer was added to the eluted proteins to a 
final concentration of 1× and samples were heated at 95 °C for 5 min. Samples were 
resolved by 10% SDS−PAGE or 7.5% SDS−PAGE and immunoblotting with anti-Myc 
9E10 cell culture supernatant at a dilution of 1:100 (33), anti-Flag mouse monoclonal M2 
antibodies at a dilution of 1:1000 (Sigma-Aldrich), anti-G6PDH antibodies at a dilution 
of 1:50000 (Sigma-Aldrich), and the secondary antibodies goat antimouse or goat 
antirabbit at a dilution of 1:10000 (Biorad). Detection was performed with 
chemiluminescent ECL substrate (PerkinElmer). 
 
Purification of Glutathione S-transferase (GST) Fusion Proteins 
pRS316-ADH-Myc-Vps15
WD R1261A
, pRS316-ADH-Myc-Vps15
WD R1261K
, 
pRS316-ADH-Myc-Vps15
ID,WD R1261A
, pRS316-ADH-Myc-Vps15
ID,WD R1261K
, pRS316-
ADH-Myc-Vps15
ID,WD
, pRS316-ADH-Myc-Vps15
WD
, and pRS316-ADH-Myc were 
cotransformed into wildtype strains with either pRS315-ADH-Flag, pAD4M-Gpa1-GST, 
or pAD4M-Gpa2-GST. Cells were disrupted in buffer F (200 mM Tris pH 7.6, 150 mM 
NaCl, 1 mM EDTA, 0.1% Triton X-100 and 2 protease inhibitor cocktail pellets per 50 
mL) and prepared in a manner similar to that described for purification of Flag epitope 
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tagged proteins, except that the lysis time was decreased to 10 min. For determination of 
nucleotide specificity of binding, either 5 mM MgCl
2
 and 10 µM GDP or 10 mM NaF, 5 
mM MgCl
2
, 10 µM GDP, and 30 µM AlCl
3
 (GDP-AlF
4
−
) was added to buffer F. 
Supernatants were mixed with 40 µL of glutathione-Sepharose resin (GE Healthcare) 
equilibrated with buffer F. The glutathione-Sepharose resin was incubated with the lysate 
and washed in a manner similar to that described above for the immunoprecipitation of 
Flag-tagged proteins. Bound proteins were then eluted from the beads with two 20 µL 
washes of 10 mM reduced glutathione, 50 mM Tris pH 8.0 and were collected by 
centrifugation at 4900g for 1 min. 6× SDS buffer was added to the eluted proteins to a 
final concentration of 1× and samples were heated at 95 °C for 5 min. Samples were 
resolved by 10% SDS−PAGE and immunoblotting with anti-GST polyclonal antibody at 
a dilution of 1:1500 (a gift of Joan Steitz), anti-Myc 9E10 monoclonal antibodies at a 
dilution of 1:100, anti-G6PDH antibodies at a dilution of 1:50000 (Sigma-Aldrich), anti-
Ste4 antibodies at a dilution of 1:2000 (a gift of Duane Jenness), and the secondary 
antibodies goat antimouse or goat antirabbit at a dilution of 1:10000 (Biorad). Detection 
was performed with chemiluminescent ECL substrate (PerkinElmer). 
 
Cell Extract Preparation and Analysis for MAP kinase Phosphorylation and 
Carboxypeptidase Y Sorting 
Plasmids pRS315-ADH-Flag-Vps15
KD
, pRS315-ADH-Flag-Vps15
KD,ID
, pRS315-
ADH-Vps15
KD,ID,WD
-Flag, pRS315-ADH-Flag-Vps15
ID,WD
, pRS315-ADH-Vps15
ID,WD
-
Flag, pRS315-ADH-Flag-Vps15
WD
, pRS315-ADH-Vps15
WD
-Flag, and pRS315-ADH-
Flag were transformed into either wildtype or vps15Δ cells. Wildtype, vps15Δ, and 
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vps15
R1261A
 strains were also analyzed for MAP kinase phosphorylation and 
carboxypeptidase Y sorting without any additional plasmid transformation. Cells were 
grown to A
600 nm
  0.8 in 20 mL SCD-Leu and then split and either treated with 3 µM α-
MF pheromone or left untreated at 30 °C for 30 min. The reaction was stopped by 
addition of 5% trichloroacetic acid, and the cells were harvested by centrifugation and 
frozen at −80 °C. Cell extracts were prepared as previously described (34), and resolved 
by 10% SDS−PAGE and immunoblotted using p44/p42 MAP kinase antibody at 1:500 
(Cell Signaling Technology) or anti-CPY antibody at 1:2000 (a gift of Pat Brennwald), 
anti-G6PDH antibodies at a dilution of 1:50000 (Sigma-Aldrich), and the secondary 
antibody goat antirabbit at a dilution of 1:10000 (Biorad). Detection was performed with 
chemiluminescent ECL substrate (PerkinElmer). 
 
Pheromone Response Assays 
Reporter-transcription (β-galactosidase assay utilizing the pRS423-FUS1-lacZ 
plasmid) and growth arrest (halo) assays were performed as described previously (26, 
35). 
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RESULTS 
 
The structure of the Vps15 WD domain is presented in Figure 2.1. The protein 
folds as a seven-bladed propeller as predicted in a prior homology modeling analysis (5). 
As described previously, the WD repeat units are not equivalent to the blades of the 
propeller, but are comprised rather of the fourth strand of one blade and the first three 
strands of the blade that follows (36). The overall architecture of the Vps15 WD domain 
is similar to that of the transducin G protein β subunit (Gβ
1
) (36), and superposition of the 
structures with the CCP4 topological comparison program TOP yields a rms deviation of 
2.7 Å
2
 for the Cα carbons (37, 38). There are several key differences in the overall 
structures of the two proteins. The N-terminus of Gβ folds as an α-helix that extends 
away from the propeller. In the case of Vps15, the corresponding region is largely 
unstructured, and it packs against the bottom surface of the propeller. There are four 
insertions in the Vps15 propeller (Figure 2.1A): an extended loop containing a 3
10
 helix 
between WD repeats 1 and 2 (residues 1110−1121); an extension of strands 3 and 4 of 
blade 3 (residues 1156−1172); a large loop with 3
10
 helical twists within the sixth WD 
repeat (residues 1318−1351), and two additional β-strands within the seventh WD repeat 
(residues 1385−1426). 
 
Heterotrimeric G protein β subunits form obligate heterodimers with Gγ subunits. 
The interaction between Gβ and Gγ is largely hydrophobic; the first α-helix of the γ 
subunit forms a coiled-coil interaction with the Gβ N-terminal α-helix, whereas the 
second α-helix wraps into a cleft on the bottom surface of the Gβ propeller (36) (Figure 
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2.1B). As noted above, the N-terminus of the Vps15 WD repeat domain is folded against 
the bottom of the propeller (Figure 2.1C), and the stretch of N-terminal residues 
immediately before the propeller partially occlude a potential Gγ binding surface. 
However, inspection of the hydrophobic regions on the bottom surface of the propeller 
(upon removal of the N-terminus) of Vps15 indicates there is no equivalent binding cleft 
for interaction with a Gγ subunit. This finding provides an explanation for our ability to 
express, purify, and crystallize the Vps15 WD domain in the absence of an associated Gγ. 
The G protein α subunit typically interacts with Gβγ through two interfaces, termed the 
“switch interface” and the “N-terminal interface” (39). The interaction at the switch 
interface involves residues in and around switch I and switch II of Gα as well as 
conserved hydrophobic residues on the top surface of the Gβ propeller (Tyr-59, Trp-99, 
Met-101, and Leu-117 in Gβ
1
). The N-terminal interface is formed by interaction of the 
Gα N-terminal α-helix with four conserved residues in blade 1 of the Gβ propeller (Leu-
55, Lys-78, Ile-80, and Lys-89 in Gβ
1
). The Vps15 propeller provides neither of these 
binding surfaces for interaction with a Gα subunit. The region that corresponds to the 
switch interface is comprised of polar amino acids (Thr-67, Thr-113, Thr-116, and Lys-
131). Further, superposition of the Vps15 structure on the Gαβγ heterotrimer suggests the 
Vps15 residues corresponding to the N-terminal interface (Glu-62, Val-87, Lys-89 and 
Ser-104) would not form a tight interaction with the Gα N-terminal α-helix (not shown). 
The inability of the Vps15 WD domain to form these interactions, or the absence of a 
corresponding Gγ subunit, may explain our failure to isolate a stable heterodimeric 
complex of Gpa1 with the WD domain-containing fragment of Vps15 (by size exclusion 
chromatography, not shown). 
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The data presented above reveal the absence of a canonical Gα-binding interface 
within the Vps15 WD domain. Thus, we considered whether other domains of Vps15 
might contribute to Gpa1 interactions. In order to determine the possible binding role for 
these other domains, we coexpressed Gpa1 with several truncations of Vps15 including 
(a) the kinase domain alone, (b) the kinase domain with the intermediate domain, (c) full-
length Vps15, (d, e) the intermediate domain with the WD domain, and (f, g) the WD 
domain alone (Figure 2.2). Whereas Gpa1 was tagged with the Myc epitope (located 
internally to preserve function), variants of Vps15 were tagged at the N- and C-terminus 
with the Flag epitope. We eliminated from consideration any Flag-tag fusions that did not 
express. We then immunoprecipitated Vps15 and monitored the presence of 
coprecipitating Gpa1 by immunoblotting. Differences in the apparent abundance of 
Vps15 truncations could reflect differences in actual abundance or more likely 
differences in the position of the epitope tag (compare lanes f and g, containing 
Vps15
WD
-Flag and Flag-Vps15
WD
 respectively) as well as the size of the tagged protein 
(which could affect the protein transfer and immunoblot detection). As shown in Figure 
2.2, the WD domain of Vps15 is sufficient to bind Gpa1, while the kinase domain alone 
failed to interact. However, the kinase domain with the intermediate domain was capable 
of binding to Gpa1. These data indicate that the intermediate domain, in addition to the 
Gβ-like WD domain, of Vps15 contributes to the stable interaction with Gpa1. 
 
Vps15 is known to exist in a stable multiprotein complex that includes Atg14 or 
Vps38 (UVRAG in animals), as well as Vps34 and Vps30 (Beclin-1 in animals) (40-45). 
Atg14 has sequence similarity to canonical Gγ proteins (5). Thus, we investigated if the 
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Vps15 Gβ-like domain binds to the Gγ-like protein Atg14. To this end we 
immunoprecipitated each of the Vps15 truncation mutants and monitored copurification 
of Atg14 by immunoblotting, as described above for Gpa1. As shown in Figure 2.3, the 
WD domain of Vps15 is indeed sufficient to bind to Atg14. The kinase domain alone is 
also capable of binding to Atg14 (Figure 2.3). Typical G protein α subunits bind to the 
Gγ subunit indirectly, through the common binding partner Gβ. Likewise, Gpa1 bound to 
the Vps15 WD domain even in the absence of Atg14 expression (Figure 2.4). Taken 
together, these data indicate that the Vps15 Gβ-like domain exists in a multisubunit 
complex with the Gα and Gγ-like proteins. 
 
Although the crystal structure of the WD-like domain of Vps15 shows that it is 
comprised of a seven-bladed propeller structure, similar to that of canonical Gβ proteins, 
this analysis also revealed a lack of conservation in the predicted Gα-binding interface. 
The lack of a canonical Gα-binding site within Vps15 indicates that interaction must 
occur in a distinct manner. Accordingly, we undertook a molecular evolution analysis to 
identify potential binding residues within Vps15. We first generated a multiple-sequence 
alignment of Vps15 orthologs from several fungi, arthropods, mammals, and amphibians 
(Supporting Information). Invariant and highly conserved residues within this alignment 
were placed in a spatial context by mapping them onto the crystal structure of Vps15 (far 
right panel of Figure 2.1A). This analysis revealed two residues, Arg-1261 and Phe-
1262, that are invariant across all orthologs, implying a strong evolutionary pressure to 
preserve function. In addition, the side chains protrude into the solvent, making them 
available for protein−protein interactions. Two additional invariant residues were found 
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on the opposite side of the Vps15 propeller, Glu-60 and Ser-104. However, these two 
residues form multiple hydrogen bonds to each other and may therefore be important for 
structural constraints. We observed no other invariant residues on the surface of Vps15. 
To determine the importance of the conserved Arg-1261, we examined the functional 
consequences of replacing this residue within Vps15. For these experiments, we purified 
Gpa1 fused to glutathione S-transferase (GST) and monitored copurification of Vps15 or 
various Vps15 truncations. Gpa1-GST was used in this case to corroborate the results of 
the Vps15-immunopreciptation experiments shown above. Additionally, the GST 
purification method is in our experience better suited for analysis of nucleotide-
dependent interactions of G protein α and βγ subunits. Accordingly, the WD domain of 
Vps15 was coexpressed with Gpa1-GST or with a second G protein α subunit Gpa2-GST, 
used here as a negative control (Figure 2.5). Cell lysates were mixed with glutathione-
Sepharose resin, washed extensively, eluted with reduced glutathione, and analyzed by 
immunoblotting using antibodies against GST (to detect purified Gpa1 or Gpa2) and Myc 
(to detect any copurifying Vps15). Although Ste4 was tagged with Myc, it did not bind 
well with an anti-Myc antibody, and was instead detected using an anti-Ste4 antibody 
(data not shown, see Figure 2.7). As shown in Figure 2.5, the Vps15 WD domain 
copurified with Gpa1 but did not copurify with Gpa2. 
 
We then investigated the functional role of the conserved Arg (Figure 2.1). This 
residue was of particular interest because of a similarly conserved arginine “finger” 
present in most G proteins (46-52). In G protein α subunits the arginine finger acts in cis 
to stabilize the transition state, promote GTP hydrolysis, and turn off the transmitted 
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signal (46, 53). Thus, we substituted Arg-1261 in both a conservative (to Lys) and 
nonconservative (to Ala) manner, and determined the ability of each mutant to bind to 
Gpa1 as described above. As shown in Figure 2.5, substitution of Arg-1261 to either Lys 
or Ala resulted in diminished copurification with Gpa1-GST. This result indicates that 
Arg-1261 is necessary for Vps15 to bind efficiently to Gpa1. These mutants are likely to 
be properly folded given that other functions are preserved (see below). 
 
We have shown previously that Vps15 is needed for proper pheromone responses, 
including pheromone-dependent MAP kinase activation, gene transcription, and cell-
division arrest. Thus, we investigated the role of Arg-1261 in pheromone signaling. To 
monitor MAP kinase activity, cell extracts were analyzed by immunoblotting using 
antibodies against the dually phosphorylated, fully active forms of Fus3 and Kss1 (54). 
As shown previously, cells lacking VPS15 exhibit diminished Fus3 phosphorylation after 
pheromone stimulation; in contrast, cells expressing Vps15
R1261A
 exhibit wildtype levels 
of MAP kinase phosphorylation (Figure 2.6A). To monitor transcriptional activation, we 
employed a reporter comprised of a pheromone-inducible promoter and β-galactosidase 
(FUS1-lacZ). As shown previously, cells lacking VPS15 exhibit dampened induction and 
a >3-fold rightward shift in the EC
50
 for pheromone stimulation, whereas cells expressing 
Vps15
R1261A
 exhibited wildtype transcription activity (Figure 2.6C). Finally, using the 
growth arrest plate assay (halo assay), we monitored the ability of the cells to undergo 
cell division arrest in response to pheromone. Once again, Vps15
R1261A
-expressing cells 
produced wildtype zones of growth inhibition (Figure 2.6D). Therefore, while it 
contributes to Gpa1 binding, Arg-1261 does not contribute to Vps15-mediated signaling. 
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In addition to its role in pheromone signaling, Vps15 has well-established 
functions in promoting autophagy and at least two types of protein trafficking (6-8, 10, 
12, 42, 45, 55, 56). Vps15 is needed for newly synthesized vacuolar proteins, such as 
carboxypeptidase Y (CPY), to move from the endoplasmic reticulum, through the Golgi, 
to the endosome, and finally to the vacuole compartment. During transport, the newly 
synthesized CPY becomes modified in the ER to the pro-CPY1 form (67 kDa), then 
processed in the Golgi to the pro-CPY2 form (69 kDa), and finally it is modified in the 
vacuole to yield the mature protein product (61 kDa) (10, 12, 42, 55). To determine if 
Arg-1261 has any role in CPY sorting, we prepared extracts from Vps15R1261A cells, 
treated with or without pheromone, and monitored the maturation of CPY by 
immunoblotting. As shown in Figure 2.6B, vacuolar sorting of carboxypeptidase Y is 
unaffected by substitution of Arg-1261 in Vps15. 
 
We have shown above that the WD domain of Vps15 is sufficient to bind Gpa1 in 
vitro, and does so in a manner that depends on Arg-1261. Nevertheless, Vps15 is capable 
of promoting the G protein signal in vivo even when Arg-1261 is mutated. On the basis 
of these findings, we postulated that the kinase and/or intermediate domains of Vps15 
might contribute more substantially to the signaling or trafficking functions of the 
protein. For instance, we showed above that the Vps15 intermediate domain as well as 
the WD domain contributes to Gpa1 binding. Thus, we investigated the functionality of 
Arg mutant forms of Vps15 containing the intermediate domain as well as the WD 
domain. The wildtype and arginine-substituted forms of Vps15 were coexpressed with 
either Gpa1-GST or Gpa2-GST, purified, and analyzed by immunoblotting using 
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antibodies against GST and Myc (to detect any copurifying Vps15). In this case, Gpa1 
bound equally well to wildtype and mutant forms of Vps15 (Figure 2.7A). These 
findings indicate that the intermediate domain can compensate for the absence of the 
conserved arginine present in the WD domain, at least with respect to Gpa1 binding. Our 
hypothesis was that Arg-1261 functions in the manner of an arginine finger, to promote G 
protein binding and GTP hydrolysis. However, we have shown that this residue is a 
relatively minor contributor to binding. It remains to be determined if the adjacent 
conserved Phe-1262 likewise contributes to binding. 
 
Previously, we showed that Vps15 binds preferentially to the unactivated, GDP-
bound, form of Gpa1 (5). Thus, we sought to determine if Arg-1261 contributes to the 
nucleotide-dependent interaction of Vps15 with Gpa1. Wildtype and mutant Vps15 were 
coexpressed with Gpa1-GST, then lysed in the presence of either GDP or GDP plus 
AlF
4
−
, a transition state mimic that induces the activated conformation of Gα. As 
observed previously for full-length Vps15, the WD domain with the intermediate domain 
of Vps15 bound preferentially to GDP-bound (unactivated) Gpa1. The arginine mutants 
likewise bound preferentially to unactivated Gpa1 (Figure 2.7B). These results indicate 
that neither the kinase domain nor the conserved Arg-1261 is necessary to maintain the 
nucleotide-specificity of Vps15 binding to Gpa1. 
 
The data presented above reveal that the intermediate and WD domains of Vps15 
both contribute to Gpa1 binding, and are sufficient to confer nucleotide-specificity of 
interaction. We have shown previously that Vps15 is required for G protein signaling at 
46 
the endosome (5). However, we have already ruled out a role for the conserved arginine 
in sustaining the G protein signaling function of Vps15. These findings suggest that 
domains necessary for binding and for signaling functions may not fully overlap. Thus, 
we investigated which domains of Vps15 contribute to pheromone signaling, using the 
same signaling assays described above in Figure 2.6. First we determined which domains 
of Vps15 are necessary to confer MAP kinase activation. As shown in Figure 2.8A, the 
kinase domain with the intermediate domain is sufficient to sustain MAP kinase 
activation in response to pheromone. Likewise, by the transcription-reporter assay the 
kinase domain with the intermediate domain is sufficient to confer wildtype 
transcriptional activation (Figure 2.8C) and growth-inhibition responses (Figure 2.8D). 
Finally, the kinase domain with the intermediate domain of Vps15 is sufficient to sustain 
at least some degree of carboxypeptidase Y maturation (Figure 2.8B). Neither the WD 
domain alone nor the WD domain with the intermediate domain is sufficient to sustain 
the signaling functions of Vps15 (Figure 2.8A−D). 
 
Taken together, the findings presented above indicate that the WD domain of 
Vps15 has a Gβ-like structure and is sufficient to bind Gpa1, but cannot by itself sustain 
signaling. Whereas the conserved arginine contributes to Gpa1 binding, it is not required 
for Gpa1 signaling. By comparison, the intermediate domain also contributes to Gpa1 
binding, and together with the kinase domain is both necessary and sufficient for 
pheromone signaling and vacuolar sorting activities. 
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DISCUSSION 
 
The yeast pheromone response pathway represents one of the best-characterized 
models for the study of G protein signaling and regulation. Upon pheromone activation, 
Gα as well as Gβγ subunits activate downstream effectors. Release of Gβγ at the plasma 
membrane leads to activation of the MAP kinases Fus3 and Kss1 (2). At the endosomal 
membrane, activated Gα transmits a signal that requires the PtdIns 3-kinase and results in 
activation of Fus3 (5, 6). The endosomal PtdIns 3-kinase Vps34 is a direct binding 
partner for the GTP-activated form of Gpa1, and this interaction leads to elevated 
production of PtdIns 3-P. Thus, G protein signaling can occur at the endosomal 
membrane as well as at the plasma membrane. 
 
Given that cell surface receptors and the Gβγ subunits Ste4 and Ste18 are 
concentrated at the plasma membrane, we considered whether there is an alternative Gβγ 
pair at the endosomal membrane. Here we have examined the extent to which Vps15 
resembles more typical Gβ proteins such as Ste4. We have shown that Vps15 indeed 
possesses many structural and functional characteristics of canonical Gβ proteins. Both 
Vps15 and Ste4 are direct binding partners of Gpa1, and both bind preferentially to the 
unactivated (GDP-bound) form of the protein. Here we have demonstrated that Vps15 
contains a seven-bladed propeller structure resembling that of known Gβ proteins. We 
showed further that the Gβ-like domain is sufficient to bind to Gpa1, as well as to the 
putative Gγ protein Atg14. As documented previously for typical Gγ subunits, Atg14 is 
not necessary to bridge the interaction of the Gα (Gpa1) and Gβ-like (Vps15) proteins. 
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While these findings highlight similarities between Vps15 and canonical Gβ proteins, 
there are also many important differences. Ste4 is predominantly expressed at the plasma 
membrane. Vps15 was previously shown by cell fractionation and fluorescence 
microscopy methods to be located at the endosome, Golgi, and vacuolar membranes (11, 
57). Typical Gβγ pairs are anchored to the plasma membrane through prenylation (and in 
some cases palmitoylation) of Gγ (58), while the Vps15/Atg14 complex is anchored to 
the endosomal membrane through myristoylation of Vps15 (12). 
 
We have documented additional important differences between Ste4 and Vps15. 
The Gβ protein Ste4 is necessary to transmit the signal to downstream effectors at the 
plasma membrane (2). In contrast, the Gβ-like WD domain of Vps15 is neither necessary 
nor sufficient to transmit the G protein signal at the endosome. Our efforts to dock Gpa1 
onto the β propeller domain of Vps15 (using a similar orientation to that of known Gα-
Gβ pairs) revealed no conserved interactions, indicating that the Gpa1-Vps15 interface 
must differ from that of more typical G protein subunits. Indeed, we have shown here that 
binding also entails the intermediate domain. Moreover, the intermediate domain and 
kinase domain are necessary and sufficient to restore full pheromone responsiveness to a 
vps15 mutant strain. While binding and signaling activities of Vps15 require the 
intermediate domain, the sequence of this region provides no clues as to its function. 
Thus, we limited our analysis to the intermediate domain in conjunction with the well-
defined kinase and/or WD domains only. These observations lead us to conclude that the 
Gβ-like WD domain of Vps15 serves primarily as a scaffold that promotes assembly of 
key signaling pathway components, including Gpa1 and Atg14, whereas the kinase 
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domain and the intermediate domain transmit the signal. The same domains that mediate 
Vps34 interaction (14) also mediate G protein signaling and vacuolar sorting. 
 
Taken together, our observations highlight the close interplay of Vps15 in G 
protein signaling and vacuolar sorting, and are consistent with our earlier suggestion that 
PtdIns 3-P production is required for both processes (5). Thus just as Gpa1 promotes 
PtdIns 3-P production, this second messenger could in turn be required for proper 
trafficking of Gpa1 or some other critical signaling protein, whether or not that protein 
actually binds to PtdIns 3-P. The signaling phenotypes exhibited by vps15 and vps34 are 
not the result of some global defect in membrane trafficking, however; deletion of VPS30 
or VPS38 also result in a strong vacuolar sorting defect similar to vps15 and vps34 (59), 
but neither component is required for Gpa1 signaling (5). Indeed of the dozens of 
vacuolar trafficking mutants that have been described, only vps15 and vps34 attenuate 
Gpa1 signaling (59). 
 
In summary, we have defined the signaling and binding functions of specific 
domains within Vps15. Our findings highlight important similarities and differences 
between canonical Gβ-proteins at the plasma membrane and Gβ-like proteins located 
within the cell. 
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Table 2.1 Data collection parameters and processing statistics.  Values in parenthesis 
refer to the highest resolution shell.   
 
Native KAu(CN)2
Unit Cell (Å) a , b  = 85.5, c  = 132.8 a , b  = 86.0, c  = 132.8
Resolution (Å) 50.0–1.80 50.0–2.20
Observed reflections 518207 637020
Unique reflections 50964 29652
I /σ(I) 36.0 (1.6) 39.2 (12.3)
Completeness (%) 96.5 (71.2) 100 (100)
Redundancy 10.2 (6.8) 21.5 (22.0)
R sym (%) 8.1 (52.7) 9.7 (24.9)
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Table 2.2  Phase calculation and refinement statistics.  Values in parenthesis refer to 
the highest resolution shell. 
 
 
 
 
Phasing
Resolution (Å) 50–2.5
Number of sites (SHELX) 4
FOM after MLPHARE 0.284
Anomalous R cullisa 0.76 (0.82)
FOM after DM 0.819
Refinement
Resolution (Å) 50–1.80
Rwork/R free (%) 20.9/24.6
Number of atoms
     Protein 3163
     Water 200
Average B-factor (Å2)
      Protein 35.4
      Water 41.0
R.m.s. deviations
      Bond lengths (Å) 0.014
      Bond angles (°) 1.524
aRcullis = lack of closure/anomalous difference
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Table 2.3  Primer sequences. 
Primer Name Sequence (5’-3’) 
Vps15fn GAG CTC ATG GGG GCA CAA TTA TCA C 
Vps15ksrn GAG CTC TTA AAT GCC ACG ATA TTT ATT CAG 
Vps15klrn GAG CTC TTA ATA GCT GTT GCT GAC GAC TAC C 
Vps15wdlfn GAG CTC TAT CGT GGC ATT TTC TTC CC 
Vps15rn GAG CTC TTA TTG GAA GAT TCC AAT AAG 
Vps15wdsfn GAG CTC GAA GGC GAC GTT GAA AGC 
Vps15fc CCC GGG ATG GGG GCA CAA TTA TCA C 
Vps15rc CCC GGG TTG GAA GAT TCC AAT AAG 
Vps15wdlfc CCC GGG ATG TAT CGT GGC ATT TTC TTC C 
Vp15wdsfc CCC GGG ATG GAA GGC GAC GTT GAA AG 
Atg14fn GAG CTC CAT TGC CCA ATT TGC CAC CAT AG 
Atg14rn GAG CTC CTA GCC TAC CAC GTA CCA TCG 
2myc TC GAC ATG GAA CAA AAA TTA ATT TCT GAA GAA GAT TTA 
GCT GAA CAA AAG TTA ATT TCT GAA GAA GAC TTA G 
Vps15R1261A GAT ATA TGG GAT ATC GCT TTC AAC GTG CTG ATA AGG 
Vps15R1261K GAT ATA TGG GAT ATC AAA TTC AAC GTG CTG ATA AGG 
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FIGURE LEGENDS 
 
Figure 2.1. Structure of the Vps15 WD repeat domain and comparison to the beta 
subunit of transducin (Gβ1).  (A) Left: ribbon diagram of Gβ1.  Blades of the propeller 
are numbered consecutively, as are the strands of one blade. Center:  ribbon diagram of 
Vps15 WD repeat domain, in the same orientation as Gβ1.  Breaks within the structure 
are indicated by dotted lines.  The first break occurs at residue 1041; the short stretch of 
amino acids visible before this break are shown in this part of the figure but deleted in 
others.  Colored regions highlight major differences in the propeller’s structure: blue, N-
terminus; magenta, insertion between WD repeats 1 and 2; gold, insertion between WD 
repeats 2 and 3; green, insertion within WD repeat 6; yellow, insertion within WD repeat 
7.  The N-terminus and corresponding loop regions of Gβ1 are colored similarly.  Right: 
space filling model of Vps15 WD repeat domain (same orientation) with residues highly 
conserved across genera colored salmon, and those which are invariant colored red.  Arg-
1261 and Phe-1262 reside on the surface in the loop between WD repeats 4 and 5.  (B) 
Left: ribbon diagram of Gβγ oriented to highlight the interaction between the beta and 
gamma (red) subunits.  Center: surface representation of Gβγ in the same orientation.  
Right: surface representation of Gβ1 alone, with hydrophobic residues colored light grey 
to show the binding cavity for Gγ1.  (C) Left: ribbon diagram of Vps15 WD repeat 
domain oriented as Gβ1 in panel B.  The N-terminal loop is colored gold.  Center: surface 
rendering to illustrate partial occlusion of the potential gamma subunit binding surface.  
Right: surface representation following removal of the N-terminal loop, with hydrophobic 
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residues colored light grey to reveal the absence of a binding cavity for a gamma-like 
subunit.  This figure was contributed by Janeen Vanhooke and Brenda Temple. 
 
Figure 2.2. The WD domain of Vps15 is sufficient but not necessary to bind Gpa1. 
Detergent-solubilized extracts (Total) from cells expressing the indicated Flag fusion 
proteins and Gpa1 fused to Myc were incubated with Flag resin, eluted with 3X Flag 
peptide (Flag IP), resolved by 7.5% or 10% SDS-PAGE, and analyzed by 
immunoblotting with antibodies against Flag, Myc, and G6PDH (Load control).  C-
terminally tagged forms of (a) and (b) did not express.  IP, immunoprecipitation.  WD, 
WD domain.  KD, kinase domain.  ID, intermediate domain.  *, indicates protein of 
interest. 
 
Figure 2.3. The WD domain of Vps15 is sufficient but not necessary to bind Atg14. 
Detergent-solubilized extracts (Total) from cells expressing the indicated Flag fusion 
proteins and Atg14 fused to a triple Myc epitope were incubated with Flag resin, eluted 
with 3X Flag peptide (Flag IP), resolved by 10% SDS-PAGE, and analyzed by 
immunoblotting with antibodies against Flag, Myc, and G6PDH (Load control). IP, 
immunoprecipitation.  WD, WD domain.  KD, kinase domain.  ID, intermediate domain. 
*, indicates protein of interest. 
 
Figure 2.4. Atg14 is not necessary to mediate the interaction of Vps15 and Gpa1. 
Detergent-solubilized extracts from wild-type (WT) and atg14Δ mutant cells expressing 
the indicated Flag fusion proteins and Gpa1 fused to a Myc epitope were incubated with 
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Flag resin, eluted with 3X Flag peptide, resolved by 10% SDS-PAGE, and analyzed by 
immunoblotting with antibodies against Flag, Myc, and G6PDH (Load control). IP, 
immunoprecipitation.  WD, WD domain.  KD, kinase domain.  ID, intermediate domain. 
*, indicates protein of interest. 
 
Figure 2.5. Arg-1261 is necessary for the WD domain of Vps15 to bind efficiently to 
Gpa1. Detergent-solubilized extracts (Total) from cells expressing the indicated Myc 
fusion proteins and Gpa1 or Gpa2 fused to GST were incubated with glutathione-
Sepharose resin, eluted with glutathione (GST PD, pulldown), resolved by 10% SDS-
PAGE, and analyzed by immunoblotting with antibodies against GST, Myc and G6PDH 
(Load control). PD, pulldown.  GST, glutathione-Sepharose.  WD, WD domain.  RA, 
Arg-1261 to Ala.  RK, Arg-1261 to Lys.  
 
Figure 2.6. The conserved Arg-1261 is not necessary for G protein signaling at the 
endosome. (A) Wild-type (WT), vps15Δ, and VPS15R1261A (Vps15RA) strains were treated 
with 3µM α-mating factor (MF) for 30 minutes and analyzed by immunoblotting using 
antibodies against p44/p42 and G6PDH (Load control). (B) The same samples as in panel 
(A) analyzed using antibodies against carboxypeptidase Y (CPY) and G6PDH. (C) The 
same strains were transformed with a plasmid containing a pheromone-inducible FUS1-
lacZ reporter; transcriptional activation was measured by monitoring β-galactosidase 
activity in response to pheromone. (D) The same strains were plated and treated with 45 
micrograms of α factor to induce cell division arrest.   α-MF, alpha mating factor.  RA, 
Arg-1261 to Ala. 
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Figure 2.7. Arg-1261 is not necessary for larger truncations of Vps15 to bind to 
Gpa1. (A) Detergent-solubilized extracts (Total) from cells expressing the indicated Myc 
fusion proteins and Gpa1 or Gpa2 fused to GST were incubated with glutathione-
Sepharose resin, eluted with glutathione (GST PD), resolved by 10% SDS-PAGE, and 
analyzed by immunoblotting with antibodies against Myc, GST, Ste4 and G6PDH (Load 
control). (B) Detergent-solubilized extracts from cells expressing the indicated Myc 
fusion proteins and Gpa1 fused to GST were lysed in the presence of either GDP or GDP-
AlF4-, incubated with glutathione-Sepharose resin, eluted with glutathione, and analyzed 
by immunoblotting with antibodies against Myc, GST, Ste4, and G6PDH. PD, pulldown.  
GST, glutathione-Sepharose.  RA, Arg-1261 to Ala.  RK, Arg-1261 to Lys. 
 
Figure 2.8. The kinase domain with the intermediate domain of Vps15 is necessary 
to promote G protein signaling at the endosome. (A) WT and vps15Δ cells expressing 
the indicated Flag fusion proteins or empty vector were treated with 3 µM α-mating 
factor (MF) for 30 minutes and analyzed by immunoblotting with antibodies against 
p44/p42 and G6PDH (Load control). (B) The same samples were analyzed using 
antibodies against carboxypeptidase Y (CPY) and G6PDH. (C) The same strains were 
transformed with a plasmid containing a pheromone-inducible FUS1-lacZ reporter; 
transcriptional activation was measured by monitoring β-galactosidase activity in 
response to pheromone. (D) The same strains were plated and treated with 1.5-45 
micrograms of α factor to induce cell division arrest.  α-MF, alpha mating factor.  
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Figure 2.4 
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Figure 2.5 
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Figure 2.6 
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Figure 2.7 
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Figure 2.8 
Chapter 3 
 
The Regulation of Fus3  
72 
ABSTRACT 
 
In the yeast Saccharomyces cerevisiae pheromones promote a series of events 
leading to mating. These events include activation of the MAP kinases Fus3 and Kss1, 
altered gene transcription, and cell cycle arrest in G1. A crystal structure of Fus3 reveals 
a unique cluster of basic amino acids that could potentially serve as a phospholipid 
binding site (Lys, Arg, His) or site of ubiquitination (Lys).  We have previously 
demonstrated that the phosphatidylinositol (PtdIns) 3-kinase Vps34 is required for full 
activation of Fus3 but not Kss1. Here we show that Fus3 activity binds to the Vps34 
product PtdIns(3)P.  Mutations of basic residues did not alter PtdIns(3) sensitivity or gene 
transcription activation; however, these Fus3 mutants were less able to undergo 
ubiquitination, and less able to phosphorylate the cell cycle regulator Far1 or induce cell 
cycle arrest.  These findings reveal a new mode of signal regulation that concomitantly 
alters MAPK ubiquitination substrate specificity and control of the cell cycle. 
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BACKGROUND AND INTRODUCTION 
 
              G proteins are found in organisms from plants to fungi to humans, and they 
mediate responses to a wide array of signals.  Activation of receptors on the cell surface 
results in the G protein α subunit releasing GDP and binding GTP.  The newly activated 
Gα then dissociates from the G protein βγ subunit dimer. Either the activated, GTP-
bound form of Gα, Gβγ, or both go on to stimulate downstream effector proteins within 
the cell. Prominent examples include members of the MAPK (mitogen activated protein 
kinase) and phosphatidylinositol (PtdIns) 3-kinase families. Upon GTP hydrolysis the G 
protein subunits reassemble and signaling stops (1, 2). 
               
In the yeast Saccharomyces cerevisiae, G protein signaling pathways mediate the 
cell-to-cell communication responsible for essential processes, including those leading to 
mating. Stimulation of G protein-coupled receptors by mating pheromones triggers a 
series of responses that includes activation of the MAP kinases Fus3 and Kss1, 
morphological changes, cell cycle arrest, and cell fusion. As in other pathways, the Gα 
and Gβγ subunits in yeast act in a cooperative manner to transmit the signal. Whereas 
Gβγ  (Ste4/Ste18) is required to initiate MAP kinase activation and functions in the 
pathway that originates from the plasma membrane (3), the GTP-activated form of Gα 
(Gpa1) amplifies the response in a pathway that originates from the endosome (4-6). The 
pathway mediated by the Gα protein functions through Vps15 and Vps34, the regulatory 
and catalytic subunits respectively of the only PtdIns 3-kinase in yeast (7-15). Whereas 
GDP-bound Gpa1 binds directly to Vps15, the GTP-bound (activated) form of Gpa1 
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binds directly to Vps34 and promotes elevated PtdIns(3)P production (5). 
               
The production of PtdIns(3)P by Vps34 is critical for the function of many 
pathways.  It is thought that signaling by Vps34 is provoked by the recruitment of 
proteins that possess PtdIns(3)P binding domains (13). PtdIns(3)P binding domains 
include FYVE domains, zinc-finger binding domains (16), and PX domains (17).  
Pathways mediated by PtdIns(3)P include, but are not limited to, assembly of PtdIns(3)P 
binding proteins to regulate early endosomal docking and fusion (18, 19), assembly of the 
retromer complex required for endosome to Golgi transport (20), and the ubiquitin 
dependent sorting of internalized membrane proteins (21). Ubiquitin is added to specific 
lysine residues within a protein, and generally leads to degradation of a substrate protein.  
Ubiquitination has been shown to be important in the regulation of many components of 
the G protein signaling pathway, including Gpa1 and Ste7 (22-26). 
 
Whereas pheromone stimulation through Gβγ leads to activation of both Fus3 and 
Kss1, signaling through Gpa1 is more selective and leads to activation of Fus3 in 
preference to Kss1. Moreover, deletion of Vps34 or pharmacological inhibition of 
PtdIns(3)P production results in a selective loss of Fus3 activity (5). However the 
mechanism by which Vps34 or PtdIns(3)P modulates Fus3 activity is unclear.  The 
crystal structure of Fus3 reveals a cluster of basic amino acids that could serve as a site 
for PtdIns(3)P binding or Fus3 ubiquitination (25).  Here we demonstrate that PtdIns(3)P 
binds Fus3.  Mutation of basic patch residues of Fus3 does not affect regulation by 
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PtdIns(3)P , but it does decrease ubiquitination of Fus3 and alter Fus3 substrate 
specificity in vivo.  
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EXPERIMENTAL PROCEDURES 
 
Strains and Plasmids 
Standard methods for the growth, maintenance, and transformation of yeast and 
bacteria and for the manipulation of DNA were used throughout. Yeast Saccharomyces 
cerevisiae strains used in this study are BY4741 (MATa leu2Δ met15Δ his3Δ ura3Δ), 
BY4741-derived gene deletion mutants containing the G418-resistance marker 
(Invitrogen), and BY4741-derived strains containing a C-terminal GFP tag (Invitrogen) 
or RFP.  All RFP-tagged strains were a gift from Erin O’Shea (Harvard University). 
  
Previously described yeast shuttle vectors and expression plasmids are pRS315-
ADH-Flag (contains ADH1 promoter/terminator and a Flag epitope that can be added 3’ 
with an XmaI site) (27), pAD4M, pAD4M GPA1Q323L (4), Yep24-Myc-Ubiquitin (28) 
(Also know as pND186 from Nick Davis, Wayne State University), pRS423-FUS1-LacZ 
(29), pGEX-2T, pGEX-2T-FUS3 (30), pETARA-miniFar1 (31) (from Wendell Lim, 
University of California), pRS316-FUS3, pRS313-FUS3 (from Nan Hao, University of 
North Carolina), pRS316-HA-FAR1 (also known as pMP974, from Mike Tyers, 
University of Toronto), pRS316-HA-FAR1T63A and pRS316-HA-FAR1T306A (from 
Michal Nagiec, University of North Carolina).  Plasmid pRS406-SNF7-RFP was 
constructed by PCR amplification of SNF7-RFP (using primers 5’-TCC CCG CGG GGA 
ATG TGG TCA TCA CTT TTT GG-3’ and 5’-CCA TCG ATG GGC CTT AGG CGC 
CGG TGG AG-3’) and subcloning into the SacII and ClaI sites of pRS406. Plasmid 
pRS406-FUS3-GFP constructed by PCR amplification of FUS3 (using primers 5’-GAA 
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AGG AAA CTA GTA TGC CAA AGA G-3’ and 5’-GAT AAT GAA AGC TTA CTA 
AAT ATT TCG TTC-3’) and subcloning into the SpeI/HindIII sites of pUG35 (contains 
C terminal enhanced GFP containing optimal codons for Candida albicans and 2 
substitutions near the chromophore shown to increase fluorescence) (from J. H. 
Hegemann, Dusseldorf) and then subcloning the FUS3-GFP fusion into the XbaI-KpnI 
sites of pRS406. Genomic integration was directed by AflII digestion. The strain FAR1-
GFP fus3Δ was created by plasmid amplification of the fus3::G418 cassette using primers 
in the promoter and terminator regions of Fus3 (using primers 5’-CGG GAT CCG CAG 
CGA CTG CAC TAA ACT AGA GG-3’ and 5’-CGG AAT TCG TCT AGT AAG ACG 
GTC TCT TGC TGC-3’).  The FAR1-GFP strain was then transformed with the purified 
PCR product and selected for growth on G418.  Plasmids pRS316-FUS3H333A/K335A and 
pRS406-FUS3H333A/K335A-GFP were constructed using the QuikChange Site-directed 
Mutagenesis Kit (Stratagene) and mutagenic primers (5’-GCT TCT TCG AGT TTG 
ATG CCT ACG CGG AGG CAC TAA CG-3’, and its complement).  Plasmid pRS315-
ADH-FUS3-Flag was created by PCR amplification of FUS3 (using primers 5’-CCC 
GGG ATG CCA AAG AGA ATT ATA TAC-3’ and 5’-CCC GGG ACT AAA TAT 
TTC GTT CCA AAT G-3’) and subcloning into the Xma1 site of pRS315-ADH-Flag.  
Plasmids pRS315-ADH-FUS3K335R-Flag and pRS315-ADH-FUS3H333A/K335A-Flag were 
created using the QuikChange Site-directed Mutagenesis Kit and mutagenic primers 
(using primers 5’-CTT CGA GTT TGA TCA CTA CAG GGA GGC ACT AAC GAC G-
3’ and 5’-CGT CGT TAG TGC CTC CCT GTA GTG ATC AAA CTC GAA G-3’).   
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Cell Extract Preparation for MAP kinase, Far1, and Ste7 Phosphorylation 
Strains were grown to an A600nm ∼ 0.8 in the appropriate selective media, and then 
split and either treated with 3 µM α-factor pheromone or left untreated at 30°C for 30 
minutes.  The reaction was stopped through the addition of 5% trichloroacetic acid, the 
cells were harvested by centrifugation and the pellets were frozen at -80°C. Cell extracts 
were prepared as previously described (32), resolved by 10% SDS-PAGE and 
immunoblotted using p44/p42 MAP kinase antibody at 1:500 (9101 L, Cell Signaling 
Technology), anti-Fus3 antibodies at 1:500 (sc-6773, Santa Cruz), and anti-G6PDH 
antibodies at a dilution of 1:50,000 (A-9521, Sigma-Aldrich).  Secondary antibodies used 
were horse radish-conjugated goat anti-rabbit (172-1019, Biorad) or rabbit anti-goat (sc-
2768, Santa Cruz) at a dilution of 1:10,000.   
  
To analyze Far1 and Ste7 phosphorylation, samples were resolved by 7 % SDS-
PAGE and immunoblotting with rat anti-HA 3F10 antibodies (to detect Far1-HA) 
(1187423001, Roche Applied Science) at 1:1000 and goat anti-Ste7 antibodies (sc-6770, 
Santa Cruz) at 1:200. Protein concentration was determined by Dc protein assay (500-
0111, Biorad). Antibody detection was by enhanced chemiluminescence detection. 
  
Pheromone Response Assays 
Growth arrest (halo) and reporter transcription assays (β-galactosidase) utilizing 
the plasmid pRS423-FUS1-lacZ were performed as previously described (29, 33). 
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Purification of Flag Epitope-tagged Proteins 
Strains expressing the indicated plasmids were grown in a 100 ml culture to 
A600nm ∼ 0.25.  The cells were then treated with 100mM copper sulfate for 3 hours at 
30°C to induce expression of myc-ubiquitin.  Cultures were then split and either treated 
with 3 µM α-factor or left untreated at 30°C for 1 hour.  The reaction was stopped by the 
addition of sodium azide to a final concentration of 10mM, and the cells were harvested 
by centrifugation and frozen at -80°C.  The procedure for Flag purification has been 
described in detail previously (6).  Briefly, cells were disrupted in buffer A (50 mM Tris-
Cl pH 8.0, 200 mM NaCl, 0.1% Triton X-100, 25 mM beta-glycerophosphate, 1 mM 
EDTA) with 2 protease inhibitor cocktail pellets per 50 ml (Roche) for 15 minutes at 4°C 
using a vortex.  Lysates were clarified through centrifugation twice at 16000g, and an 
equal volume and protein concentration of each lysate was applied to 40 µl of Flag 
affinity resin (Sigma-Aldrich).  After a two hour incubation with gentle rotation at 4°C, 
the beads were washed five times with 500 µl buffer A and bound proteins eluted with 
two 20µl washes of 0.25 mg/ml 3X Flag Peptide (Sigma-Aldrich) diluted in buffer A.  
The samples were resolved by 10% SDS-PAGE and immunoblotting with anti-Myc 9E10 
cell culture supernatant at a dilution of 1:100 (34), anti-Flag mouse monoclonal M2 
antibodies at a dilution of 1:1000 (F3165, Sigma-Aldrich), and anti-G6PDH antibodies 
and secondary antibodies as described above. 
  
Microscopy Analysis 
Yeast cells containing integrated FUS3-GFP or FUS3H333A/K335A-GFP and SNF7-
RFP were grown to A600nm ~ 0.8 and split.  Cells were treated either with 3µM α-factor or 
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left untreated at 30°C for one hour and harvested by centrifugation.  Cells were visualized 
by differential interference contrast (DIC) and fluorescence microscopy using a Nikon 
Eclipse TE2000-S with the following laser lines: 488 nm (Blue Argon, for GFP), 568nm 
(Yellow Krypton, for RFP), and 633nm (Red Helium Neon for DIC), photographed with 
a Hamamatsu digital camera, and analyzed with MetaMorph Version 5.0 software. 
Quantitative analysis of translocation was done in cells containing either integrated 
pRS406-FUS3-GFP or pRS406-FUS3H333A/K335A-GFP plasmids and integrated pRS403-
SNF7-RFP plasmid (endosomal marker). Images were analyzed using the Just Another 
Colocalization Plugin (JACoP) (35) with ImageJ (NIH). Preprocessing of images 
included subtraction of a background average level. Colocalization of GFP and RFP 
fluorescence was evaluated by extracting the Manders Overlap Coefficients using the 
manual thresholding option of the JACoP Plugin; these values are indicators of the 
coincidence between the signal in the green and red channels. 
  
Yeast cells containing integrated FAR1-GFP in a fus3Δ background were 
transformed with pRS315-ADH-Flag, pRS315-ADH-FUS3-Flag, pRS315-ADH-
FUS3K335R-Flag or pRS315-ADH-FUS3-H333AK335A-Flag and grown to A600nm ∼ 0.6.  Cells 
were split, and either treated with 3µM α-factor or left untreated at 30 °C for two hours 
and harvested by centrifugation.  Cells were imaged as described above and analyzed 
using ImageJ (NIH). 
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E. coli expression of GST fusion proteins 
GST, GST-Fus3 and GST-Fus3H333A/K335A were purified from E. coli BL21 (DE3) 
cells as described (5). GST-miniFar1-6HIS was purified from Rosetta (DE3) pLysS cells 
(Novagen, EMD Biosciences) as described (31). Glutathione was removed from protein 
samples on Econo-Pac 10 DG columns (Bio-Rad). 
  
In vitro kinase assay 
For phosphorylation time-course analysis, GST-Fus3 and GST-Fus3H333A/K335A 
proteins (~0.9 mM) were incubated either with myelin basic protein MBP ~14 mM) 
(Sigma) or GST-miniFar1-6HIS (~1.5 mM) in kinase buffer (25 mM HEPES, 50 mM 
NaCl, 25 mM MgCl2, 1 mM DTT, pH 7.5) 200 mM ATP, 5 mCi [ γ-32P]-ATP/sample at 
30 ºC. Samples were taken at the indicated times and the reaction was terminated by the 
addition of 6X SDS-PAGE sample buffer. Samples were resolved by 15 % (MBP) or 6 % 
(Far1) SDS-PAGE. 32P incorporation was detected using a PhosphorImager SI 
(Molecular Dynamics). 
  
Lipid binding assays 
Lipid binding assays were performed using PIP Strips from Echelon Biosciences 
Inc. according to the manufacturer’s recommended protocol. Briefly, PIP strips were 
blocked in 3% fatty acid-free bovine serum albumin in TBST (20 mM Tris, 150 mM 
NaCl, 0.1% Tween 20, pH 7.5) for 1 hr and incubated with the protein of interest (0.5-1 
mg/ml in 3% BSA-TBST) overnight at 4º C. PIP strips were washed 3 times in TBST and 
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bound protein was detected using anti-GST monoclonal antibodies (G1160, Sigma) at 
1:1,000.   
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RESULTS 
  
 Previous mammalian studies have shown that PtdIns 3-kinase promotes activation 
of the mammalian MAP kinases ERK1 and ERK2 (36, 37).  Similarly, activation of a 
yeast MAP kinase Fus3 requires the function of Vps34 and Vps15, the catalytic and 
regulatory subunits of the only known phosphatidyl-3-kinase present in yeast (5, 6).  We 
therefore set out to determine if Fus3 is regulated directly by PtdIns(3)P.   
  
We first considered whether Fus3 binds directly to PtdIns(3)P. To this end we 
monitored association of purified GST-Fus3 with a panel of lipids spotted onto 
nitrocellulose membranes. The immobilized protein was detected with anti-GST 
antibodies. As shown in Figure 3.1B, Fus3 binds to several mono-phosphorylated PtdIns 
lipids including PtdIns(3)P (Figure 3.1B, asterix). In contrast, Fus3 does not appear to 
bind to poly-phosphorylated phosphoinositides, possibly because they contain additional 
negative charges (requiring additional ion-pairing positively-charged residues within 
Fus3) or because they are substantially larger than PtdIns(3)P (requiring a larger binding 
pocket within the protein). 
  
Whereas PtdIns(3)P apparently binds to Fus3, attempts to quantify the affinity of 
interaction (e.g. by surface plasmon resonance or liposomal binding) were unsuccessful 
(Mark Lemmon, personal communication) (38). As an alternative approach to confirm 
binding, we investigated whether PtdIns(3)P modulates Fus3 kinase activity. To this end 
we measured Fus3 catalytic activity in vitro in the presence of various concentrations of a 
84 
soluble PtdIns(3)P analog. As shown in Figure 3.1C and D, PtdIns(3)P has a very 
modest dose-dependent effect on Fus3 catalytic activity. At PtdIns(3)P concentrations of 
20-40 µM Fus3 activity was elevated, while at high concentrations (>150 µM) the 
activity was diminished. A similar dose-response relationship was evident whether using 
the test substrate myelin basic protein (MBP, Figure 3.1C) or Fus3 itself (auto-
phosphorylation, Figure 3.1D). 
  
We next investigated the residues in Fus3 responsible for PtdIns(3)P binding.  In 
support of this effort we inspected the crystal structure of Fus3, and found a patch of 
eight basic amino acids that form a potential binding surface for acidic phospholipids 
(Figure 3.1A) (31).  Substitution of six of the eight residues abolished kinase activity 
(data not shown); thus we focused our efforts on the remaining two substitutions.  Both of 
these residues are found in Fus3 but not in the closely related MAPK Kss1.  Purified 
Fus3 and Fus3H333A/K335A were incubated with purified Far1 or MBP (myelin basic 
protein) and [ γ-32P]-ATP, as described above in the methods.  Substitutions at positions 
333 and 335 (Fus3H333A/K335A) yielded near-wildtype catalytic activity towards myelin 
basic protein (MBP, Figure 3.1E, lower band) as well as Fus3 auto-phosphorylation 
(Figure 3.1E, upper band, Figure 3.1F, lower band). Fus3H333A/K335A was also fully able 
to phosphorylate a known cellular substrate Far1 (31, 39) (Figure 3.1F upper band). Thus 
Fus3H333A/K335A is fully functional as a protein kinase.   
  
Having determined that the H333A/K335A mutation does not abrogate the kinase 
function of Fus3, we set out to determine if the mutation affected Fus3’s ability to bind 
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PtdIns(3)P.  As can be seen in Figure 3.1C and D, the dose-dependent effects of 
PtdIns(3)P on Fus3H333A/K335A mirrored those obtained with the wild type Fus3 protein. 
Thus Fus3H333A/K335A is fully functional as a protein kinase, but remains fully sensitive to 
PtdIns(3)P.  
 
Having determined that Fus3H333A/K335A is able to function normally as a protein 
kinase in vitro, we set out to determine the functionality of the Fus3H333A/K335A mutant in 
vivo. Full activation of Fus3 is dependent on pheromone treatment, as well as the 
presence of Vps15 and Vps34 and production of PtdIns(3)P (5, 6). Given that Fus3 
appears to bind to PtdIns(3)P, we investigated whether Fus3 localized with endosomes 
where PtdIns(3)P is made, and if Fus3 localization is affected by the presence or absence 
of PtdIns(3)P.  Fus3 is already known to localize to the nucleus, cytoplasm, and rarely, 
small puncta within the cell (40, 41).  We treated cells with pheromone, or left them 
untreated, for one hour.  We then examined the distribution of Fus3-GFP as compared to 
the endosomal marker Snf7-RFP (40).  As can be seen in Figure 3.2, Fus3 is 
concentrated in the nucleus and more rarely in puncta, but these puncta do not colocalize 
significantly with the endosomal compartment either before or after treatment with 
pheromone (quantified in Table 3.1).  Likewise, we observed no difference in Fus3 and 
Fus3H333A/K335A localization either in the presence or absence of PtdIns(3)P production 
(data not shown). 
 
 We then measured activation of Fus3 following stimulation of cells.  In these 
experiments, we probed TCA precipitated cell lysates with antibodies specific for 
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phosphorylated and activated forms of the MAPKs Fus3 and Kss1.  As can be seen in 
Figure 3.3A, Fus3H333A/K335A is fully phosphorylated following a 30 minute treatment of 
pheromone, indicating that mutation does not affect activation of Fus3 in vivo.  We next 
sought to ascertain if the mutant is able to sustain transcriptional activation following 
pheromone stimulation.  In these experiments, cells containing the pheromone-inducible 
reporter FUS1-lacZ were treated with varying doses of pheromone, and total 
transcriptional activation was measured colorimetrically.  As can be seen in Figure 3.3B, 
Fus3H333A/K335A confers wildtype levels of activation in a reporter transcription assay.  
Finally, we sought to determine if the mutant played any role in the growth arrest 
response, which we monitored using a halo assay.  As seen in Figure 3.3C, 
Fus3H333A/K335A shows smaller and more turbid halos as compared with wildtype Fus3.  
These smaller, more turbid halos are an indication that mutating the basic patch of Fus3 
results in a diminished growth arrest response.  Therefore, while the Fus3H333AK335A 
mutation has no effect on one branch of the pheromone signaling pathway, one that is 
mediated by Fus3 and Kss1 and leads to new gene transcription, it has a clear effect on a 
second branch of the pathway that leads to growth arrest and requires Fus3 but not Kss1.  
 
The Fus3H333AK335A growth arrest phenotype appears to mirror the phenotype for 
mutants of the protein Far1.  Far1 plays a critical role in many responses of the cell to 
pheromone, including oriented growth towards a mating partner (42) and cell cycle arrest 
(43, 44).  Fus3 has been shown to be required for phosphorylation of Far1 at Thr-306, 
and this phosphorylation event as well as the putative phosphorylation site Thr-63 are 
necessary for cell cycle arrest (39, 45). Moreover, mutation of Thr-306 to Ala leads to a 
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substantial reduction in the electrophoretic mobility shift that accompanies Far1 
phosphorylation (39) and slightly smaller and more turbid halos, while mutation of 
another phosphorylation site Thr-63, with no ensuing reduction in electrophoretic 
mobility shift, results in smaller and very turbid halos (Figure 3.4 and (39)).   These 
small, turbid halos are similar to those we observed with our Fus3 mutants (compare 
Figure 3.4 and 3.3C and (39)). Thus we considered whether the Fus3H333A/K335A mutation 
impairs phosphorylation of Far1 and/or Far1-mediated growth arrest in vivo. 
 
Far1 phosphorylation in cells can be easily monitored by immunoblotting, since 
the phospho-protein exhibits dramatically diminished electrophoretic mobility (45). As 
shown in Figure 3.5A and B (upper panels), Far1 phosphorylation was indeed severely 
diminished in cells expressing the Fus3H333A/K335A mutant, as compared with the wild-type 
form of the kinase. Phosphorylation of another known substrate, Ste7, was completely 
unaffected (Figure 3.5A and B, middle panels). Thus when Fus3 is mutated in a manner 
that disrupts the basic patch, but preserves catalytic activity, Far1 is poorly 
phosphorylated and the cells fail to undergo proper cell cycle arrest. This loss of activity 
in vivo is particularly surprising given that Fus3 is fully able to phosphorylate Far1 in 
vitro (Figure 3.1F). 
 
Given that Fus3 binds to Far1, we considered whether the Fus3H333A/K335A mutant 
disrupted the localization of Far1 (2, 42, 46).  Far1-GFP fus3Δ cells were transformed 
with either wildtype Fus3 or Fus3H333A/K335A.  The cells were treated with pheromone and 
monitored for Far1 localization.  As can be seen in the top panels of Figure 3.6, while 
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some cells deficient in Fus3 are still capable of forming the characteristic shmoo in 
response to pheromone, there is little localization of Far1 to the shmoo tip.  The bottom 
set of panels show cells expressing the Fus3H333A/K335A mutant.  Here, we observe 
wildtype shmoo formation as well as wildtype localization of Far1 (compare to cells 
expressing wildtype Fus3 directly above).  Therefore, although the Fus3H333A/K335A mutant 
shows a reduction in growth arrest in response to pheromone, this phenotype is not the 
result of a deficiency in Far1 translocation. 
    
Taken together, the available data indicate that the basic patch mutant results in 
diminished growth arrest, but normal kinase activity, binding to PtdIns(3)P, Fus3 
activation, Far1 localization and transcription-reporter activity.  We therefore wondered if 
the lysine we identified in the basic patch of Fus3 could potentially be a site of regulation 
by ubiquitination. Many components of the pheromone pathway are known to be 
ubiquitinated (22, 26), and this modification occurs on Lys residues.  To test if Lys-335 is 
ubiquitinated, we made a more conservative mutation within the basic patch of Fus3, in 
which just the lysine was replaced with arginine.  We coexpressed wildtype Flag-tagged 
Fus3 or Fus3K335R together with an inducible form of myc-tagged ubiquitin.  Myc-tagged 
ubiquitin was used because it is easier to detect and slows the degradation of substrates 
(28).  We then purified Fus3, and monitored the co-purification of myc-ubiquitin by 
immunoblotting.  As can be seen in Figure 3.7, Fus3 is ubiquitinated in a manner that 
does not depend on pheromone stimulation.  Additionally, mutation of lysine 335 of Fus3 
results in a decrease in the ubiquitination of Fus3, although some Fus3 is still modified, 
as is commonly seen when the primary ubiquitination site is altered. Thus, Lys-335 
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appears to be one site of ubiquitination in Fus3, although an additional site of 
ubiquitination probably exists.  These findings should be regarded as preliminary.   
 
Having determined that a mutation in the basic patch of Fus3 apparently reduces 
ubiquitination of Fus3, we set out to determine the ability of Fus3K335R to respond to 
pheromone and to regulate Far1 localization.   As can be seen in Figures 3.3 and 3.6, 
Fus3K335R exhibits diminished growth arrest, but normal Fus3 activation, Far1 
localization and transcription-reporter activity. Thus the activities of Fus3K335R mirror 
those observed for Fus3H333A/K335A. Taken together these findings reveal a vital role for 
the basic patch of Fus3 in one pathway activated by pheromone and mediated by Fus3, as 
well as in the ubiquitination of Fus3.  While mutations of the basic patch do not affect the 
ability of Fus3 to be activated by pheromone or to stimulate new gene transcription, they 
do dampen its ability to mediate growth arrest in response to pheromone, potentially 
through its inability to phosphorylate Far1 at residue 306 in vivo. 
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DISCUSSION 
 
              Here we investigate two potential new regulators of Fus3 activity: PtdIns(3)P 
and ubiquitin.  Of these, regulation by ubiquitin can be uncoupled by substitutions in the 
basic patch of Fus3. Quantitative analysis reveals that Fus3H333A/K335A is fully competent 
to phosphorylate multiple substrates including Far1 and Fus3 in vitro. However, the 
Fus3H333A/K335A mutant exhibits a diminished ability to sustain cell cycle arrest and 
phosphorylate Far1 in vivo.  Additionally, mutation of Lys335 results in a decrease in 
ubiquitination of Fus3.  The loss of mobility shift combined with a decrease in growth 
arrest mirrors the changes already reported for mutations that disrupt phosphorylation of 
Far1.  Gartner et al. have previously reported that mutation of Thr306 to Ala in Far1 
results in a decrease in responsiveness to pheromone as well as a loss of mobility shift of 
Far1, while mutations of other putative phosphorylation sites in Far1, including Thr63, 
have no effect on mobility.  They proposed that Thr306 is a major phosphorylation site of 
Far1 by Fus3, and that phosphorylation at this locus is required for activation of Far1 
(39).  We propose that mutation of the basic patch of Fus3 may result in an abolition of 
the ability of Fus3 to phosphorylate Far1 in vivo but not in vitro. 
 
We have also tested the hypothesis that PtdIns(3)P regulates Fus3 catalytic 
activity. This model stems from our previous observations that the PtdIns(3)-kinase in 
yeast is required for efficient propagation of the G protein signaling pathway activated by 
pheromone. Gpa1 colocalizes with Vps15 and Vps34 at the endosome, binds to Vps15 
and Vps34 directly and in a guanine nucleotide-dependent manner, promotes an increase 
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in cellular PtdIns(3)P, and triggers endosomal translocation of PtdIns(3)P-binding 
proteins. Moreover, the interaction of Gpa1 with Vps34 triggers most of the events 
typically seen after treatment with mating pheromones, including activation of Fus3. 
Deletion or pharmacological inhibition of Vps34 abrogates all of these Gpa1 signaling 
phenotypes including Fus3 activation. Thus genetic, cell biological, biochemical, and 
pharmacological evidence support the model that Gpa1 activates Vps34 and that Vps34 
activates Fus3. In comparison, Kss1 is much less responsive to changes in Gpa1 or Vps34 
activity (5, 6). 
 
Taken together, these findings indicate a potential role for mono-phosphorylated 
phosphoinositides in Fus3 activation.  However, the functional effects of PtdIns(3)P are 
modest at best.  Nevertheless this result leaves open the possibility that other proteins 
bind to PtdIns(3)P and thereby contribute to the regulation of Fus3.  For example, Fus3 
activation requires the MAPK scaffolding protein Ste5, while Kss1 activation does not.  
Moreover, Ste5 was shown to bind to PtdIns(4)P and PtdIns(4,5)P2 in vitro (47).  The 
possibility remains that Fus3 activity is modulated by Ste5 binding to PtdIns(3)P, 
PtdIns(4)P or PtdIns(4,5)P2. 
 
Regardless of the precise mechanism, it is evident that PtdIns(3)P acts 
intracellularly to alter MAP kinase activation.  Thus PtdIns(3)P meets the criteria of a 
second messenger as originally defined by Earl Sutherland for cAMP in the late 1950s.  
In contrast to many other second messengers however, PtdIns(3)P does not diffuse 
throughout the cytoplasm but remains associated with the endosomal membrane where it 
92 
is made (48).  Thus PtdIns(3)P serves as a highly specific marker of subcellular 
localization, as well as of G protein activity. PtdIns 4-P and PtdIns 4,5-P2 are produced in 
different subcellular locations, and these differences could contribute further to signaling 
specificity and activity.  In any event, these discoveries suggest an important and 
expanded role for phosphoinositides in the pheromone-response pathway.  Current 
investigations are aimed towards purifying and reconstituting known substrates together 
with the Ste5 protein complex (includes Ste5, Ste11, Ste50, Ste7, and Fus3) and various 
phosphoinositide lipids. 
 
In summary, we have demonstrated regulation of the MAP kinase Fus3 through 
ubiquitination.  Under normal, pheromone-stimulated conditions, Fus3 promotes Far1 
phosphorylation, and morphogenesis leading to cell division arrest. When ubiquitination 
is diminished, Far1 phosphorylation and cell cycle arrest are compromised.  Other Fus3-
mediated responses are unaffected. The separation of two arms of a G protein signaling 
pathway by the mutation of a single residue in Fus3 represents a powerful tool to 
distinguish the many roles that Fus3 plays in the pathway.  Given the broad conservation 
of G protein, MAP kinase, and PtdIns 3-kinase signaling in eukaryotes, the mechanisms 
elucidated here for Fus3 are likely to be conserved in other signaling programs and in 
other cellular systems. 
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Table 3.1 Colocalization of Fus3 and Snf7 in the presence and absence of 
pheromone. 
 - pheromone + pheromone 
Fus3 Range: 1.6-2.7% 
Average: 2.1% 
Range: 1.9-9.3% 
Average: 4.5% 
Fus3H333A/K335A Range: 1.0-3.1% 
Average: 2.1% 
Range: 1.7-3.5% 
Average: 2.7% 
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FIGURE LEGENDS 
 
Figure 3.1. PtdIns(3)P binds to Fus3. (A) Crystal structure of Fus3 (Protein Databank 
entry 2B9F) showing the ATP substrate (spacefilled representation in red, green, and 
blue), Fus3 phosphorylation sites (spacefilled residues in orange) as well as a cluster of 
basic amino acids (“basic patch”, spacefilled residues in blue) (31) identified by visual 
inspection and presented using PyMOL (DeLano Scientific). (B) Lipid binding properties 
of Fus3. PIP strips (Echelon) spotted with the indicated lipids were mixed with purified 
GST or GST-Fus3. Bound protein was detected with anti-GST antibodies. In vitro 
phosphorylation of MBP (C), Fus3 and Fus3H333A/K335A (auto-phosphorylation) (D) in the 
presence of different concentrations of PtdIns(3)P. 32P incorporation was quantified 
following 6% or 15% SDS-PAGE using a PhosphorImager SI and ImageQuant Software. 
Data shown are averages of at least two independent experiments. In vitro 
phosphorylation of MBP (P-MBP) (E), mini-Far1 (P-Far1) (F), and Fus3 
(autophosphorylation, P-Fus3) (E, F) by Fus3 and Fus3H333A/K335A over time.  This figure 
was contributed by Janna Slessareva. 
 
Figure 3.2. Basic patch mutants of Fus3 show normal localization in the presence 
and absence of pheromone.  Cells containing integrated Fus3-GFP or Fus3H333A/K335A-
GFP and Snf7-RFP were transformed with an empty vector and left untreated or treated 
with 3µM α-factor for one hour.  Cells were monitored by microscopy for colocalization 
of Fus3 and Snf7, an endosomal marker. 
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Figure 3.3. The basic patch of Fus3 is necessary for one branch of the G protein 
signaling pathway mediated by Fus3. (A) Wild-type (WT), fus3Δ, and far1Δ strains 
were transformed with the indicated plasmids and treated with 3µM α-mating factor for 
30 minutes and analyzed by immunoblotting using antibodies against p44/p42, Fus3 and 
G6PDH (Load control). (B) The fus3Δ strains were transformed with a plasmid 
containing a pheromone-inducible FUS1-lacZ reporter; transcriptional activation was 
measured by monitoring β-galactosidase activity in response to pheromone. (C) The 
fus3Δ strains were plated and treated with 45 micrograms of α factor to induce cell 
division arrest.  Fus3KR refers to the basic patch single point mutant Fus3K335R.  Fus3HAKA 
refers to the basic patch double point mutant Fus3H333A/K335A. 
 
Figure 3.4. Far1 phosphorylation mutants show reduced cell cycle arrest in response 
to pheromone. A far1Δ strain was transformed with the indicated plasmids and were 
plated and treated with 45 micrograms of α factor to induce cell division arrest. 
 
Figure 3.5. An intact basic batch of Fus3 promotes phosphorylation of Far1 in vivo.  
Far1 mobility was analyzed by immunoblotting in fus3Δ (A) and fus3Δkss1Δ (B) strains 
transformed with a plasmid containing either no insert (vector), Fus3 or Fus3H333A/K335A. 
Cells were treated with 3 µM α factor for the indicated times and resolved by 7 % SDS-
PAGE and immunoblotting. Pheromone-dependent phosphorylation of Far1 (P-Far1) and 
Ste7 (P-Ste7) results in an electrophoretic mobility shift detected using antibodies against 
Far1 (HA epitope) or Ste7. Note that the slowest-migrating form of Far1 is the fully 
phosphorylated species. Note also that a 60 min pheromone treatment results in elevated 
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Far1 expression. G6PDH, loading control. Band intensity was quantified by densitometry 
and analyzed using ImageJ.  This figure was contributed by Janna Slessareva. 
 
Figure 3.6. Basic patch mutants of Fus3 show normal localization of Far1 in 
response to pheromone. Far1-GFP fus3Δ cells were transformed with either wildtype 
Fus3, Fus3K335R or Fus3H333A/K335A and left untreated or treated with 3 µM α-factor for 
two hours.  Cells were monitored by microscopy for shmoo formation and translocation 
of Far1 to the shmoo tip. 
 
Figure 3.7. Fus3 ubiquitination is reduced by mutation of the basic patch. Detergent-
solubilized extracts from fus3Δ cells expressing the indicated Flag fusion proteins and 
ubiquitin fused to a Myc epitope were incubated with Flag resin, eluted with 3X Flag 
peptide, resolved by 10% SDS-PAGE, and analyzed by immunoblotting with antibodies 
against Flag, Myc, and G6PDH (Load control). *, indicates protein of interest. 
 
 
102 
Figure 3.1 
 
 
 
103 
Figure 3.2 
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105 
Figure 3.4 
 
106 
Figure 3.5 
 
107 
Figure 3.6 
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Chapter 4 
 
The Kinase Domain of Vps15 
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INTRODUCTION 
 
G protein signaling is highly conserved in organisms from yeast to humans.   We 
have shown that, in addition to the pathway induced by pheromone that originates from 
the plasma membrane, there is a parallel and complementary pathway that originates 
from the endosome (1-3).  This endosomal pathway requires Vps34 and Vps15, the 
catalytic and regulatory subunits respectively of the only known phosphotidylinositol-3-
kinase (PI3K) present in yeast (2, 4, 5).  The pathway preferentially activates the MAP 
kinase Fus3, and produces most, but not all, of the same signaling outputs as does the 
pathway that originates at the plasma membrane (2). 
 
Vps15 is a large protein with three primary domains: an N-terminal kinase 
domain, a C-terminal 7 WD-40 repeat domain, and an intermediate domain that bridges 
these two domains and contains multiple heat repeats that are important for protein-
protein interactions (2, 6-8).  Vps15 is a known Ser/Thr protein kinase, and is believed to 
autophosphorylate, although no other substrates of its kinase activity are known (6, 9, 
10).  It has been noted that mutations of the kinase activity of Vps15 also result in a 
disruption of its association with binding partners, including Vps34, which itself is a 
protein kinase (7).  Moreover, the kinase activity of Vps15 is required for full activation 
of the endosomal G protein signaling pathway (2).  We have shown that it is the kinase 
domain with the intermediate domain that is both necessary and sufficient to bind to 
Gpa1Gα and well as to propagate the G protein signal in response to pheromone, while the 
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WD domain of Vps15 serves as a scaffold to assemble the various binding partners of 
Vps15 (4). 
 
To further elucidate the role of the kinase domain of Vps15 in pheromone-
mediated G protein coupled signaling in the cell, we sought to determine if it is the 
activation of Vps15 by phosphorylation or the kinase activity of Vps15 itself that is 
required for G protein coupled signaling.  We also sought to identify potential sites of 
phosphorylation in Vps15, and determine the effect of mutation of these sites on Vps15’s 
role in various signaling pathways, including G protein signaling. 
 
Before we could make further inroads into determining the role of the kinase 
domain of Vps1 on G protein signaling, we sought to confirm the reports of its purported 
kinase activity.  Doubts were raised about Vps15’s function as a protein kinase based on 
two primary pieces of evidence.  The first is that mutations in the kinase domain of 
Vps15 that result in a loss of its “autophosphorylation”, also result in a loss of interaction 
with binding partners, including Vps34 (7).  It is therefore theoretically possible that 
mutations of the “kinase activity” of Vps15 actually just disrupt an interaction between 
Vps15 and the protein that phosphorylates it.  Second, in early experiments done to show 
Vps15 is autophophorylated, Vps15 may have not been purified to homogeneity (indeed, 
Vps34 was probably purified with it since Vps15 and Vps34 form a tight association), 
and so it is possible that the phosphorylation of Vps15 in these experiments was actually 
due to a contaminating kinase and not to the kinase activity of Vps15 itself. 
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Here we confirm that Vps15 is indeed phosphorylated, and that mutation of the 
kinase activity of Vps15 abolishes phosphorylation of Vps15.  We also show that 
phosphorylation of Vps15 is abolished in the absence of Vps34.  Finally, we demonstrate 
that the absence of Vps34 also results in an extreme reduction of Vps15’s total protein 
level in the cell.  
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EXPERIMENTAL PROCEDURES 
 
Strains and Plasmids 
Standard methods for the growth, maintenance, and transformation of yeast and 
bacteria and for the manipulation of DNA were used throughout. Yeast Saccharomyces 
cerevisiae strains used in this study are BY4741 (MATa leu2Δ met15Δ his3Δ ura3Δ), and 
BY4741-derived gene deletion mutants containing the G418-resistance marker 
(Invitrogen).  Previously described plasmids and yeast shuttle vectors are: pRS315-ADH-
Flag (contains ADH1 promoter/terminator and a Flag epitope that can be added 3’ with an 
XmaI site) (11), pRS316-VPS34N736K (2), and pRS315-ADH-VPS15-Flag (4).  Plasmid 
pRS315-ADH-VPS15E200R-Flag was created by using the previously described mutagenic 
primers (2) and performing QuikChange Site-directed mutagenesis on the pRS315-ADH-
VPS15-Flag plasmid. 
 
Metabolic Labeling Experiments 
The metabolic labeling procedure is based on a previously described method (12).  
Briefly, 50 mls of transformed cells were grown to an A600 nm of ∼0.8 in selective media.  
The cells were centrifuged at 1200g for 5 minutes and washed once with 25 mls of 
ddH2O.  Cells were then resuspended in 35 mls of phosphate-free selective media and 
transferred to a fresh 250 ml flask. 1mCi of 32P was added to each flask, and the cells 
were grown with shaking for 1 hour at 30°C.  The cells were then spun down and the 
media discarded.  The cells were washed once with 25 mls ddH2O and the wash was 
discarded.  Cells were then washed once with 0.5 ml ddH2O and transferred to an o-ring 
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screwcap tube.  Any remaining ddH2O wash was removed and pellets were frozen at -
80°C.  Pulldown experiments were then performed as described below. 
 
Purification of Flag Epitope-tagged Proteins 
For strains that had not previously undergone metabolic labeling, strains 
expressing the indicated plasmids were grown in a 50 ml culture to A600nm ∼ 0.8.  Growth 
was stopped by the addition of sodium azide to a final concentration of 10mM, and the 
cells were harvested by centrifugation and frozen at -80°C.  The procedure for Flag 
purification has previously been described in detail (4).    Briefly, cells were disrupted by 
glass bead lysis in buffer A (50 mM Tris-Cl pH 8.0, 200 mM NaCl, 0.1% Triton X-100, 
25 mM beta-glycerophosphate, 1 mM EDTA) with 2 protease inhibitor cocktail pellets 
per 50 ml (Roche) for 15 minutes at 4°C using a vortex (for metabolic labeling 
experiments, 400mM NaCl was used in buffer A).  Lysates were clarified through 
centrifugation twice at 16000g, and an equal volume and protein concentration of each 
lysate was applied to 40 µl of Flag affinity resin (Sigma-Aldrich).  After a two hour 
incubation with gentle rotation at 4°C, the beads were washed five times with 500 µl 
buffer A and bound proteins eluted with two 20µl washes of 0.25 mg/ml 3X Flag Peptide 
(Sigma-Aldrich) diluted in buffer A.  The samples were resolved by 10% SDS-PAGE and 
immunoblotting with anti-Flag mouse monoclonal M2 antibodies at a dilution of 1:1000 
(F3165, Sigma-Aldrich).  The secondary antibodies used was horse radish-conjugated 
goat anti-mouse (170-1011, Biorad) at a dilution of 1:10,000. 
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RESULTS 
 
 The first step in investigating the kinase activity of Vps15 was confirming that it 
is in fact phosphorylated, as has been reported.  As can be seen in Figure 4.1, Vps15 is 
phosphorylated in vivo as measured by the incorporation of radioactive phosphate.  This 
phosphorylation event is abrogated when the kinase activity of Vps15 is abolished by the 
mutation E200R. 
  
 As detailed above, mutation of the kinase activity of Vps15 has also been shown 
to result in a disruption of the interaction of Vps15 and many binding partners, including 
Vps34, which has also been shown to be a protein kinase (7).  We therefore wondered if 
Vps15 would still be able to undergo a phosphorylation event in the absence of Vps34.  
As can be seen in Figure 4.2, the phosphorylation of Vps15 in vivo as measured by 
metabolic labeling is abolished in vps34Δ cells.   
 
While it is apparent that Vps34 is necessary for Vps15 to become phosphorylated, 
it is not clear if Vps34 actually phosphorylates Vps15, or if it is necessary for the 
stabilization for Vps15.  To determine if Vps34 is necessary for the stable expression of 
Vps15, we immunoprecipitated Flag-tagged Vps15 from vps15Δ and vps34Δ cells and 
looked at abundance of purified protein.  As can be seen in Figure 4.3, in the absence of 
Vps34, overall protein levels of Vps15 are dampened, indicating that the presence of 
Vps34 is necessary for Vps15 to be expressed. 
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We were then interested to see if Vps34 binding to Vps15 is sufficient for stable 
expression of Vps15.  In order to do test the role of Vps34 binding in Vps15 stability, we 
used a point mutation of Vps34, Vps34N736K, that is deficient in both protein kinase and 
PI3K activities, but has been shown by two-hybrid to be capable of binding to Vps15 (7).  
As can be seen in the preliminary data presented in Figure 4.4, Vps34N736K appears to 
result in reduced expression of Vps15, indicating that some aspect of the protein kinase 
and PI3K activities may be necessary for the expression of Vps15.  Further experiments 
are necessary to confirm these data. 
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DISCUSSION AND SUMMARY 
 
 The kinase domain of Vps15 is integral to many aspects of Vps15’s role in the 
cell, from binding to Vps34, to transmitting the G protein coupled signal, to vacuolar 
protein sorting (as monitored by the sorting of Carboxypeptidase Y) (5).  While Vps15 
has long been presumed to be a protein kinase, many aspects of its reported kinase 
activity have remained unclear.  As mentioned previously, point mutations of the kinase 
domain of Vps15 result in an interruption of Vps15’s interaction with binding partners 
(7), and, as described above, the autophosphorylation activity of Vps15 has never been 
proven conclusively.  Before we could further investigate the role of the kinase domain in 
G protein signaling, it was therefore necessary to show that Vps15 is actually a kinase. 
 
 Here, we have shown that Vps15 is phosphorylated, and that a point mutation of 
Vps15 abolishes phosphorylation of Vps15.  We have also shown that Vps15 is no longer 
phosphorylated when Vps34 is not present.  Additionally, preliminary data appears to 
show that a form of Vps34, Vps34N736K, that has no kinase activity or PI3K activity, but 
is capable of binding to Vps15, also results in a drop in total Vps15.  These data clearly 
show that Vps34 is necessary for the expression of Vps15, but the exact role of Vps34 in 
the phosphorylation of Vps15 is unclear.  It is possible that fully active Vps34 is 
necessary for the stable expression of Vps15, and that Vps34 is necessary for Vps15 
autophosphorylation or phosphorylation by another protein.  It is also possible that Vps34 
is the kinase that phosphorylates Vps15. 
 
118 
FUTURE DIRECTIONS 
 
 While much progress has been made, at least two major questions remain 
unanswered.  First, is Vps15 a protein kinase?  If so, what is the role of Vps15 
autophosphorylation?  Second, how does ubiquitination alter Fus3 kinase activity? 
 
 In order to more fully investigate the kinase domain of Vps15 as well as the role 
of Vps34 in Vps15 phosphorylation, we have been working in coordination with 
Jonathan Backer, M.D. at the Albert Einstein College of Medicine, an expert in the field 
of PI3Ks.  The Backer lab has found unique point mutations in the kinase domain of 
mammalian Vps15 that result in the typical phenotype seen with catalytically inactive 
(kinase dead) forms of Vps15, namely a loss of both kinase activity and binding to 
Vps34.  However, when these kinase dead forms of Vps15 are incubated with ATP 
analogs adpated by the Backer lab, they remain kinase dead but regain their ability to 
bind Vps34.  A great deal of research has been done on the ability of ATP analogs to act 
as inhibitors of kinase activity (13-15), however Dr. Backer speculates that in the 
mammalian Vps15 mutants, the ATP analogs may actually be inducing a conformational 
change that allows Vps15 to bind to Vps34.  The use of ATP analogs is proving to be 
useful in pharmacology, as well as a powerful tool to gain insight into the mechanisms of 
action of kinase pathways (13-15).  However, this tool is not without its hurdles to be 
overcome.  In particular, in order to use some ATP analog inhibitors one must reengineer 
the binding pocket of the kinase in a manner that allows the inhibitor to bind successfully, 
as well as determine the most effective ATP analog for the kinase of interest (13-15).   
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We are working with Dr. Backer to make a similar set of Vps15 mutants in yeast 
that are integrated with a Flag-tag under the control of the endogenous Vps15 promoter.  
If these mutants act in a manner similar to the mammalian mutants, they will be uniquely 
positioned to allow us to determine the role of Vps34 in Vps15 phosphorylation. As these 
Vps15 mutants will still be capable of binding to Vps34, and potentially other binding 
partners, we will be able to investigate solely the kinase activity of Vps15.   This system 
will allow us to determine if it is the kinase activity of Vps15 that is required for 
autophosphorylation, or if Vps15 is still phosphorylated in the absence of its kinase 
activity, which would be an indication that it is Vps34, or another protein kinase, that is 
responsible for the phosphorylation of Vps15.  
 
If Vps15 is found to be phosphorylated even with mutations in its putative kinase 
domain that allow it to interact with Vps34, we will attempt to identify the kinase 
responsible for the phosphorylation of Vps15 and determine residues in Vps15 that 
undergo phosphorylation.  In order to identify the kinase responsible for the 
phosphorylation of Vps15, we will examine the phosphorylation state of Vps15 in strains 
deleted with each of the 120 known non-essential kinases present in yeast, and investigate 
which kinase deletion strain results in a lack of phosphorylation of Vps15.  To determine 
the sites of phosphorylation in Vps15 as well as the role of pheromone treatment in the 
phosphorylation of Vps15, we will perform large scale batch purification of tagged-full 
length Vps15 from Saccharomyces cerevisiae cells that have been left untreated or 
treated with pheromone.  Purified Vps15 will then undergo liquid chromatography-mass 
spectrometry to identify phosphorylated residues.  Having identified phosphorylated 
120 
residues in Vps15, we will mutate these residues and determine the effect of a lack of 
Vps15 phosphorylation on both G protein signaling and the PI3K activity of Vps34 in 
cells. 
 
More research also remains to be performed on the basic patch present in Fus3 
and its role in G protein signaling.  Experiments will be undertaken to further confirm 
that mutations in the basic patch of Fus3 result in a decrease in the ubiquitination of Fus3 
by utilizing a 0K form of myc-ubiquitin, so only mono-ubiquitinated Fus3 will be 
purified. A single Fus3 band will make differences in ubiquitination more apparent and 
easier to quantify. Future experiments may be undertaken to determine if mutations of the 
basic patch of Fus3 result in a decreased association between Fus3 and its binding 
partners, with special attention paid to the association between Fus3 and Far1.  Mutations 
at the basic patch could abrogate an association between Far1 and Fus3, and this 
disruption may be an explanation for the reduction in Far1 phosphorylation in Fus3 basic 
patch mutants, as well as for the growth arrest defects seen in Fus3 basic patch mutants. 
 
The experiments described above represent a natural extension of the work 
performed in this thesis.  They will result in an increased understanding of G protein 
signaling at the endosome, and the mechanisms that are used to regulate this pathway.  A 
greater understanding of the endosomal pathway will give us insight into the role of the G 
protein pathway at the endosome, and the way in which it acts to complement the 
pathway that originates from the plasma membrane. 
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FIGURE LEGENDS 
 
 
Figure 4.1.  Vps15 undergoes a phosphorylation event, and mutation of the kinase 
domain abrogates phosphorylation of Vps15. Detergent-solubilized extracts from 
vps15Δ cells expressing the indicated Flag fusion proteins that had undergone metabolic 
labeling were incubated with Flag resin, eluted with 3X Flag peptide, resolved by 7.5% 
SDS-PAGE, and analyzed using a phosphorimage screen. *, indicates protein of interest.  
 
Figure 4.2. Vps15 is not phosphorylated in the absence of Vps34. Detergent-
solubilized extracts from vps15Δ cells and vps34Δ  expressing the indicated Flag fusion 
proteins that had undergone metabolic labeling were incubated with Flag resin, eluted 
with 3X Flag peptide, resolved by 7.5% SDS-PAGE, and analyzed using a 
phosphorimage screen. *, indicates protein of interest.  
 
Figure 4.3.  Vps15 has reduced expression in the absence of Vps34. Detergent-
solubilized extracts from vps15Δ cells and vps34Δ  expressing the indicated Flag fusion 
proteins were incubated with Flag resin, eluted with 3X Flag peptide, resolved by 7.5% 
SDS-PAGE, and analyzed using antibodies specific for Flag. *, indicates protein of 
interest. NSB, nonspecific Flag band used for loading control. 
 
Figure 4.4.  The PI3K and kinase activity of Vps34 are necessary for maximal 
expression of Vps15. Detergent-solubilized extracts from vps15Δ cells and vps34Δ cells 
expressing the indicated Flag fusion proteins were incubated with Flag resin, eluted with 
3X Flag peptide, resolved by 7.5% SDS-PAGE, and analyzed using antibodies specific 
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for Flag. *, indicates protein of interest. NSB, nonspecific Flag band used for loading 
control. 
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